Regenerative capacity of reactive astrocytes in vitro and in vivo by Canhos, Luisa Lange
REGENERATIVE CAPACITY OF 
REACTIVE ASTROCYTES 
IN VITRO  AND IN VIVO  
 
 
 
 
Luísa Lange Canhos 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertation der  
Graduate School of Systemic Neurosciences der 
Ludwig-Maximilians-Universität München 

June, 2018 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supervisor   
Prof. Dr. Magdalena Götz 
 
Head of Department of Physiological Genomics 
BioMedical Center – BMC 
Ludwig-Maximilians-Universität München 
 
Institute of Stem Cell Research 
Helmholtz Zentrum München 
 
 
Co-Supervisor   
PD, Dr. Swetlana Sirko 
 
Department of Physiological Genomics 
BioMedical Center – BMC 
Ludwig-Maximilians-Universität München 
 
Institute of Stem Cell Research 
Helmholtz Zentrum München 
 

First Reviewer: Prof. Dr. Magdalena Götz 
Second Reviewer: Dr. Florence Bareyre 
External Reviewer: Prof. Dr. Elly Hol   
 
Date of Submission:  28.06.2018 
Date of Defense: 24.09.2018 
 

vii 
TABLE OF CONTENTS 
1 Introduction ...................................................................................................................... 13 
1.1 Stem cells: definition and methodological approaches ..................................................... 14 
1.2 Neural stem cells ................................................................................................................ 17 
1.3 Astrocytes and their importance in CNS function .............................................................. 18 
1.4 Reactive astrogliosis ........................................................................................................... 19 
1.5 Mechanisms involved in the regulation of astrocyte reactivity ......................................... 20 
1.6 Astrogliosis and proliferation: can cortical reactive astrocytes self-renew in vivo? .......... 21 
1.7 Environment-dependent plasticity of reactive astrocytes: can they give rise to 
neurons in a neurogenic environment? .............................................................................. 22 
1.8 Origin of neurosphere-forming cells isolated from lesioned cerebral cortex: local 
dedifferentiation or migration from SEZ aNSCs? ............................................................... 22 
1.9 Aims .................................................................................................................................... 23 
2 Material and Methods ....................................................................................................... 27 
2.1 Solutions ............................................................................................................................. 27 
2.2 Experimental animals ......................................................................................................... 28 
2.3 Genotypings ....................................................................................................................... 28 
2.3.1 Tissue digestion and DNA extraction ........................................................................... 29 
2.3.2 Polymerase chain reaction ........................................................................................... 29 
2.3.3 Gel electrophoresis ...................................................................................................... 31 
2.4 Tamoxifen induction ........................................................................................................... 31 
2.5 Surgical procedures ............................................................................................................ 31 
2.5.1 Stab wound lesion ........................................................................................................ 31 
2.5.2 Transplantation in adult mice ...................................................................................... 32 
2.5.3 Transplantation in E13 embryos .................................................................................. 33 
2.5.4 Virus injections ............................................................................................................. 33 
2.6 BrdU and EdU labeling ....................................................................................................... 34 
2.7 Neurosphere culture ........................................................................................................... 35 
2.7.1 Neurosphere assay ....................................................................................................... 35 
2.7.2 Differentiation assay .................................................................................................... 36 
2.7.3 Dissociation of neurospheres for transplantation ....................................................... 36 
viii 
2.8 Immunocytochemistry ........................................................................................................ 36 
2.9 Perfusion and brain sectioning ........................................................................................... 37 
2.10 Immunohistochemistry and EdU detection ........................................................................ 37 
2.10.1 DNA denaturation with hydrogen chloride .................................................................. 38 
2.10.2 Antigen retrieval with citrate treatment ...................................................................... 39 
2.11 Confocal microscopy ........................................................................................................... 39 
2.12 Purification of cells using Fluorescence-Activated Cell Sorting ........................................... 39 
2.13 RNA extraction and quantitative RT-PCR ............................................................................ 40 
2.14 Statistical analysis ............................................................................................................... 40 
3 Results .............................................................................................................................. 43 
3.1 Modulation of the proliferative behavior of reactive astrocytes via repetitive 
pathological stimuli ............................................................................................................ 43 
3.1.1 Thymidine analogue-based analysis of cell proliferation following repetitive 
injuries: dual-labeling with BrdU and EdU .................................................................... 43 
3.1.2 Repetitive injuries induce changes in the proliferative repertoire of cortical gray 
matter astrocytes ......................................................................................................... 48 
3.1.3 Clonal analysis as a methodological approach to investigate astrocyte 
proliferation in vivo ...................................................................................................... 51 
3.1.4 Repetitive injuries induced generation of larger astrocytic clones .............................. 56 
3.1.5 Reactive astrocyte stem cell potential in vitro was not changed following 
repetitive injuries .......................................................................................................... 58 
3.1.6 Repetitive injuries induced changes in the lesion environment, evidenced by an 
exacerbated proliferation of microglia/macrophages ................................................. 60 
3.1.7 Absence of infiltrating monocytes induced a change in the mode of recruitment 
of astrocytes into proliferation following repetitive lesions ........................................ 62 
3.1.8 Age-related changes in reactive astrocyte transcriptional regulation ......................... 66 
3.2 Environment-dependent plasticity of cerebral cortex reactive astrocytes ......................... 68 
3.2.1 Transplantation as a tool to evaluate differentiation potential of cortical reactive 
astrocytes and aNSCs in vivo ........................................................................................ 68 
3.2.2 Differentiation potential of SEZ aNSCs and cortical reactive astrocytes in the 
adult hippocampal DG .................................................................................................. 70 
3.2.3 Differentiation potential of aNSCs and cortical reactive astrocytes in the 
embryonic brain ............................................................................................................ 72 
3.3 Origin of neurosphere-forming cells in the injured cerebral cortex gray matter ................ 76 
3.3.1 Analysis of origin of neurosphere-forming cells in Emx1-GFP mice ............................. 76 
3.3.2 Labeling of cerebral cortex astrocytes with an AAV reporter vector ........................... 81 
ix 
3.3.3 Analysis of origin of neurosphere-forming cells in GFP-Reporter mice injected 
with AAV-iCre viral vector to label cortical cells .......................................................... 82 
4 Discussion ......................................................................................................................... 87 
4.1 Reactive astrocytes can re-enter the cell cycle upon repetitive lesions ............................. 87 
4.2 Astrocyte proliferative pool is adaptable and driven towards homeostatic 
maintenance of astrocyte population ................................................................................ 88 
4.3 Impairment of monocyte infiltration leads to changes in the overall cellular 
environment at the penumbra ........................................................................................... 90 
4.4 Neurosphere-derived cortical reactive astrocytes are largely unable to give rise to 
neurons in vivo ................................................................................................................... 90 
4.5 Neurosphere-derived cells from the SEZ and injured cortex show very distinct 
differentiation profiles upon transplantation in neurogenic environments....................... 92 
4.6 Cortical cells give rise to neurospheres after injury ........................................................... 92 
4.7 General conclusions ........................................................................................................... 95 
References ................................................................................................................................ 97 
List of Figures .......................................................................................................................... 109 
List of Tables ........................................................................................................................... 111 
List of Abbreviations ............................................................................................................... 113 
Acknowledgments .................................................................................................................. 115 
Declaration of Author Contributions ....................................................................................... 119 
Eidesstattliche Versicherung / Affidavit................................................................................... 121 
 

11 
ABSTRACT 
Reactive astrogliosis is a reaction of the central nervous system (CNS) common to 
diverse types of injury, but only upon invasive injury a subset of reactive astrocytes 
acquires proliferative capacity in vivo and exhibits stem cell potential through self-
renewal and multipotency in vitro. Given that in the adult mammalian brain only adult 
neural stem cells (aNSCs) located in specific niches are able to self-renew and give rise to 
neurons, it is important to test to which extent reactive astrocytes can enact their NSC 
potential also in vivo when exposed to different environmental conditions. For this 
purpose, experimental mouse models were used to investigate (i) whether and to which 
extent astrocytes in the injured cerebral cortex grey matter exhibit self-renewal in vivo 
when exposed to sequential pathological stimuli; (ii) whether reactive astrocytes can 
give rise to different cell types in vivo when placed in neurogenesis-supportive 
environments.  
In order to analyze the proliferative behavior of reactive astrocytes in the adult 
murine cerebral cortex in response to repetitive pathological stimuli, I established a 
double labeling paradigm based on sequential delivery of two thymidine analogues, BrdU 
and EdU. Furthermore, in order to verify the results obtained with this paradigm I 
performed clonal analysis of reactive astrocytes using GlastCreERT2-mediated 
recombination in the R26-Confetti reporter line. Results from both experimental 
paradigms demonstrate that a distinct subset of reactive astrocytes within the cortical 
parenchyma is able to re-enter the cell cycle and give rise to 3-cell clones upon repetitive 
injuries, which had so far not been observed. Furthermore, astrocyte cell-cycle reentry is 
modulated by monocyte infiltration, as it was increased in their absence in transgenic 
CCR2-/- mice. 
Moreover, we used BrdU and EdU double labeling to investigate whether 
proliferation was a property confined to a specific subset of astrocytes, or if different sets 
of reactive astrocytes could be activated to enter cell cycle. Our analysis showed that the 
astrocyte proliferative pool is not fixed, and new astrocytes can be recruited into 
proliferation upon a second pathological event. Intriguingly, our results suggest a strong 
drive towards astroglial population homeostasis, which has so far not been described in 
these cells. 
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To analyze the differentiation capacity of RAs in vivo, cortical reactive astrocytes 
and aNSCs from the subependymal zone (SEZ) of adult actin-GFP mice cultured as 
neurospheres were transplanted heterotypically into the adult dentate gyrus (DG) and 
the E13 embryonic brain. Our analysis showed that the progeny of reactive astrocytes 
remained restricted within the glial lineage in both environments, whereas aNSCs gave 
rise to immature neurons in the DG and to mature neurons in a few regions of the 
embryonic brain. Taken together although reactive astrocytes show multipotency and 
can give rise to neurons in vitro, they are largely unable to generate neurons in vivo. 
Furthermore, in light of a recently reopened debate that questions reactive 
astrocyte stem cell potential, our results from transplantation experiments provoked 
further investigation on this matter. There is new evidence supporting that all 
neurospheres obtained from injured cortical tissue are actually originated from SEZ 
aNSCs. As our transplantation results showed a distinct differentiation profile of reactive 
astrocytes when compared to aNSCs in both host environments, we performed 
experiments to add evidence to this debate.  
For this purpose, we developed two independent experimental paradigms in 
which cortical cells (but not SEZ cells) were labeled prior to injury through double 
transgenic Emx1-GFP mice and through delivery of AAV-iCre into the cortex of floxed 
GFP-Reporter mice. Our results obtained with both experimental paradigms show that 
cells of cortical origin can give rise to neurospheres in vitro following stab wound lesion. 
Altogether, through this study we have achieved many novel insights into 
astrocyte reaction to injury, regulation of astrocytic population through different 
proliferation strategies, and into the stem cell potential of reactive astrocytes in vivo. Our 
findings advance the general understanding of astrocyte biology in the context of CNS 
pathology and open the way to many new questions in this field. 
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1 Introduction 
The adult mammalian central nervous system (CNS) has a very limited capacity 
for self-repair, as upon damage neurons get irreversibly lost, leading to functional 
disruptions in the neural circuitry. This can cause life-long lasting deficits and highly 
debilitating pathologies in affected patients. The repair of the damaged CNS continues to 
represent one of the biggest current challenges in regenerative medicine, as there are 
still no therapies available to replace neuronal loss and achieve full functional damage 
restoration in the CNS. 
Contrary to the long held idea that the adult mammalian brain was completely 
devoid of the capacity of generating new neurons, the notion that there is actually robust 
ongoing neurogenesis and neuronal integration in this system has been widely accepted 
since a few decades (Altman, 1962, 1963, Altman and Das, 1965, 1966; Goldman and 
Nottebohm, 1983; Kaplan and Hinds, 1977). The fall of this long sustained dogma 
triggered a paradigm shift in many areas of neuroscience, and changed our general 
understanding of CNS function (Gross, 2000). 
The realization that the CNS is a more plastic and dynamic system than 
previously thought led to a change in mindset that has caused a revolution in the field of 
CNS repair, as different approaches are being explored in order to replace damaged 
neurons and restore impaired neuronal function. Some approaches in particular have 
showed promising achievements (for reviews, see Barker et al., 2018; Grade and Götz, 
2017), for example by instructing local cells within the damage area to produce neurons 
(Gascón et al., 2016, 2017; Heinrich et al., 2014), as well as by introducing external cells 
into the damaged CNS to replace lost neurons (Barker et al., 2013; Falkner et al., 2016; 
Grealish et al., 2015; Michelsen et al., 2015). 
Yet another dogma that has also recently met its end is the idea that neuronal and 
glial cells were generated from different progenitors during development. The discovery 
that the stem cells that give rise to neurons during development and adulthood are in 
fact, astroglial cells (Doetsch et al., 1999; Malatesta et al., 2000; Seri et al., 2001) that 
share many common features with parenchymal astrocytes (Robel et al., 2011), has 
opened the road to many new questions for a better understanding of astrocytes in 
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different parts of the CNS, as they may be particularly valuable for endogenous repair in 
the injured CNS. 
Astrocytes are ubiquitously distributed throughout the CNS and exhibit a range of 
diverse roles that are essential for normal brain development and function, such as 
synaptic pruning, regulation of neural network activity, maintenance of tissue 
homeostasis and regulation of blood flow (Clarke and Barres, 2013; Kimelberg and 
Nedergaard, 2010). Specialized astrocytes that act as neural stem cells (NSCs) in the 
adult mammalian brain are confined to specific brain regions, the so-called neurogenic 
niches, which are, in most mammals, the lateral ventricle subependymal zone (SEZ) and 
the hippocampal dentate gyrus (DG) (Riquelme et al., 2008). Although astrocytes in the 
healthy adult brain do not proliferate outside these niches, acute invasive injury triggers 
proliferation and activation of stem cell potential in a subset of parenchymal astrocytes 
in the cerebral cortex gray matter, together with the upregulation of many genes that are 
commonly expressed in adult neural stem cells (aNSCs) (Bardehle et al., 2013; Buffo et 
al., 2008; Dimou and Götz, 2014; Götz et al., 2015; Sirko et al., 2013, 2015). 
In order to be able to explore the potential of parenchymal astrocytes in neural 
repair it is utterly necessary to acquire a better comprehension of the plasticity and 
limitations of these cells, and how they can be modulated in vivo. The aim of this project 
was to functionally investigate the stem cell potential of cerebral cortex gray matter 
reactive astrocytes following acute invasive injury through methodological approaches 
applied both in vitro and in vivo. 
On the following sections I will discuss some important concepts and technical 
implications that are relevant for understanding the specific questions we addressed in 
the scope of this project and the methodological approaches we decided to employ to 
answer our questions. 
1.1 Stem cells: definition and methodological approaches 
First and foremost, as the core question in this project involves evaluating 
reactive astrocyte stem cell potential, it is very important to first define the concept of a 
stem cell. 
Stem cells are generally defined by their behavior, and this definition is based on 
two basic hallmarks: (1) self-renewal, which is the ability of a cell to divide and generate 
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progeny identical to itself and (2) multilineage differentiation, that is the ability to give 
rise to progeny of distinct cell lineages (Figure 1A) (Weissman, 2000). Although the 
classical definition of a stem cell involves indefinite self-renewal (or at least throughout 
the lifetime of the individual) and the ability to give rise to all cell types within a tissue, it 
is hard to find cells that completely fulfill these criteria, especially in the adult organism. 
One class of adult stem cells that can fit this definition very well are the 
hematopoietic stem cells, as they can self-renew for a time that goes beyond the life span 
of an individual, and can give rise to all types of cells of the blood and immune system 
(Weissman, 2000). However, other stem cell populations have a much more limited 
capacity, such as the neural stem cells, which are at the central focus of this project. 
In summary, the definition of a stem cell is very broad and there are no agreed 
quantitative criteria for their objective classification, for example a fixed number of 
divisions the cell has to undergo to classify it as self-renewing, or of the amount of 
different cell lineages it has to produce to be defined as a stem cell. As a result, there are 
different types of stem cells with strikingly distinct capacities, as well as much debate on 
whether a given cell type classifies as a stem cell or not. 
Since stem cells are defined by their behavior and there is no specific marker to 
ultimately identify a stem cell (for example, by the expression of a certain gene), there 
are different methodological approaches to investigate cell behavior and assess whether 
a given cell type exhibits stem cell hallmarks. Importantly, this investigation can take 
place within the endogenous niche of a given cell (in situ), or the cell can be extracted 
from its original location and one can investigate how it behaves in a new environment 
(ex situ) (Figure 1B,C). Both approaches are valuable, but it is important to be aware that 
they provide different types of information about the cell’s behavior. In situ 
methodological approaches provide information on what a cell does, and the lineage it 
gives rise to; whereas through ex situ approaches one gathers information on what a cell 
can do, in other words, on its potential (Figure 1B,C) (Götz et al., 2015). 
Taking the adult neural tissue as an example, it is possible to analyze a putative 
aNSC in situ through a variety of methods to obtain information about what it does in its 
intrinsic environment, and the progeny it generates, which is referred to as its lineage 
(Figure 1B). One can analyze the incorporation of proliferation markers or ablate 
dividing cells in the niche and analyze the repopulation dynamics (Doetsch et al., 1999; 
Seri et al., 2001). Alternatively, one can actively follow the cell and its progeny over time 
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through clonal analysis (Bonaguidi et al., 2011; Calzolari et al., 2015; Encinas et al., 2011) 
or live-imaging (Barbosa et al., 2015; Pilz et al., 2018). 
 
Figure 1. Stem cell definition and methodological approaches to investigate stem cell 
properties. (A) The two defining hallmarks of stem cells are self-renewal, or the capacity to give 
rise to progeny identical to itself through cell division, and multilineage differentiation, which is 
the capacity to generate progeny of different lineages. (B) One can evaluate what a cell does in its 
endogenous environment by analyzing a cell‘s lineage. (C) Alternatively, one can investigate what 
a cell can do when relocated to a new environment, which provides information on the cell’s 
potential. A few examples for (b) and (c) are illustrated based on previous studies performed with 
aNSCs. 
Alternatively, one can investigate what a cell can do when relocated to a different 
environment, and this gives us information of a cell’s potential (Figure 1C) (Götz et al., 
2015). A seminal work that uncovered the existence of NSCs in the adult mammalian 
brain consisted on examining the behavior of neural cells in vitro through the 
neurosphere assay (Reynolds and Weiss, 1992). The neurosphere assay remains until 
today the gold standard method for testing for NSC potential, as it consists of evaluating 
the two stem cell hallmarks. Neural cells are plated in vitro in a low density, or even as 
single cells, and if they proliferate and give rise to clonal spheres that can be passaged 
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over time, they show the property of self-renewal. Furthermore, if cells contained in 
these neurospheres can differentiate into the three neural lineages (astroglial, 
oligodendroglial and neuronal), one can conclude that the cell that gave rise to this 
neurosphere is multipotent (Reynolds and Rietze, 2005). Another approach to evaluate a 
cell’s potential is to transplant it into a different environment and evaluate if it can self-
renew or give rise to different cell types under new environmental cues (Lim et al., 1997; 
Neumeister et al., 2009; Richardson et al., 2005; Suhonen et al., 1996).  
In conclusion, these different methodological approaches provide valuable 
information about how a given cell population behaves in its environment and what it 
can potentially do when exposed to different cues in a new environment. By employing 
both approaches one can gain more comprehensive information about the biology of a 
cell and how its behavior can be modulated.  
In this project we decided to employ both types of methodological approaches to 
investigate the plasticity of cerebral cortex reactive astrocytes both in situ in the cortical 
environment through cell proliferation labeling and clonal analysis; and ex situ by 
relocating these cells to different environments, in vitro through the neurosphere assay, 
and in vivo through transplantations, as I will describe in more detail in the following 
sections. 
1.2 Neural stem cells 
In the CNS the neural stem cells that are responsible for generating most of the 
neurons in the cortex during development are the radial glial cells (RGC) (Taverna et al., 
2014). These cells share several hallmarks with astrocytes, such as the expression of 
many proteins important for the regulation of neurotransmitters in the extracellular 
space (e.g. GLAST and GLT1), an important function of astrocytic cells, or ultrastructural 
hallmarks, such as glycogen granules (Götz and Huttner, 2005; Robel et al., 2011). 
Interestingly, the neural stem cells present in the adult brain (aNSCs) are derived 
from RGCs that are spared during development through slow division rates (Furutachi et 
al., 2015; Merkle et al., 2004), and also share the same common hallmarks with 
astrocytes (Beckervordersandforth et al., 2010; Llorens-bobadilla et al., 2015; Robel et 
al., 2011). 
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Of note, although both RGCs and aNSCs are classified as stem cells, they only 
exhibit their stem cell hallmarks in vitro, and fail to do so in vivo. In the neurosphere 
assay in vitro, both cell types show long-term self-renewal and multipotency, however in 
vivo their self-renewal is rather limited and they generate mostly unilineage progeny 
(Götz et al., 2015). RGCs exhibit up to 9 cell divisions in vivo and most of them generate 
either only neurons or astrocytes (Gao et al., 2014), whereas aNSCS exhibit up to 4 cell 
divisions in vivo and give rise mostly to neurons (Calzolari et al., 2015; Encinas et al., 
2011). 
1.3 Astrocytes and their importance in CNS function 
Although astrocytes have a widespread distribution and are among the most 
abundant cells in the CNS, being even more numerous than neurons in the human cortex 
(Nedergaard et al., 2003), their functional importance has only started to be elucidated in 
the past few decades. Astrocytes are a very heterogeneous cell type that exhibit a 
plethora of different functions (Oberheim et al., 2012; Zhang and Barres, 2010), amongst 
which are the regulation of ion and neurotransmitter concentrations in the extracellular 
space (Rothstein et al., 1996; Verkhratsky et al., 2014), metabolic support of neurons 
(Allaman et al., 2011), regulation of blood flow (Attwell et al., 2010; MacVicar and 
Newman, 2015), active participation in neuronal information processing (Araque et al., 
2014; Haydon, 2001), synaptic pruning (Clarke and Barres, 2013), clearance of waste 
from the brain through the glymphatic system (Jessen et al., 2015) and the 
aforementioned specialized function of neurogenesis in NSCs. 
Altogether, astrocytes exert crucial roles for CNS function and, not surprisingly, 
impairments in astrocytic function lead to CNS malfunction and diseases. An increase of 
understanding of astrocyte function has led to a paradigm shift over the last two decades, 
in which astrocytes are now starting to be seen as active players in CNS physiology and 
pathology. Growing evidence supports the idea that impairment of astrocyte function is 
the primary cause or the main factor in many different neurological diseases, a concept 
coined astropathy (Pekny et al., 2015). Therefore, a better understanding of astrocyte 
properties in different CNS pathologies can provide invaluable insights for further 
comprehension of neurological dysfunction and development of treatments for CNS 
damage or disease. 
Introduction 
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1.4 Reactive astrogliosis 
Most CNS pathologies are accompanied by a response or activation of astrocytes, 
a process termed reactive astrogliosis. Even though astrogliosis is present in nearly all 
neurological pathologies, reactive astrocytes can exhibit different types of states and 
properties depending on the pathology (Liddelow and Barres, 2017; Liddelow et al., 
2017; Pekny et al., 2015; Sirko et al., 2013). Furthermore, as astrocytes show distinct 
responses to different pathologies, and as each pathology is very complex in itself, there 
is still a debate on whether astrogliosis is beneficial or detrimental for CNS repair (Pekny 
et al., 2014; Sofroniew, 2005). There is evidence supporting a dual role of reactive 
astrocytes depending on the time window of CNS damage (Pekny et al., 2014), however 
growing evidence supports clear beneficial effects of reactive astrocytes in CNS 
neuroprotection and repair, even in supporting axonal growth (Anderson et al., 2016; 
Bush et al., 1999; Sofroniew, 2005). 
Reactive astrogliosis is generally defined as morphological, transcriptional and 
functional changes that astrocytes undergo in response to injury, such as trauma and 
ischemic events, or CNS diseases, such as neurodegenerative or neuroinflammatory 
diseases (Pekny and Pekna, 2014). There are many common hallmarks of astrogliosis 
present across different types of CNS pathology, such as cellular hypertrophy and 
upregulation of glial acydic fibrillary protein (GFAP). GFAP is the main component of 
astrocyte intermediate filaments, and its role has been implicated mainly with structural 
functions, as its deletion leads to a reduction in the resistance of CNS tissue to mechanical 
stress (Pekny and Pekna, 2004). However, GFAP function is not limited to a structural 
role, and the complexity of this protein and its functions are still being uncovered. 
Several other GFAP functions have been described, such as cellular motility or migration, 
modulation of cell proliferation, vesicle mobility, astrocyte-neuron interaction, blood-
brain barrier (BBB) permeability and myelination (Middeldorp and Hol, 2011). 
Furthermore, many different GFAP isoforms have been discovered in recent years and 
the functions of each isoform are still not well understood (Hol and Pekny, 2015). 
Interestingly, reactive astrocytes in the brain parenchyma share many hallmarks 
with NSCs, not only at the gene expression level, such as upregulation of GFAP and many 
other genes that are characteristic to NSCs (Götz et al., 2015; Robel et al., 2011; Sirko et 
al., 2015), but also functionally, as upon invasive brain injury they enter cell cycle in vivo 
and a subset of them shows stem cell potential in vitro (Buffo et al., 2008; Sirko et al., 
2013). Altogether, when exposed to certain types of CNS damage astrocytes are able to 
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resume cell proliferation and re-express proteins present in RGCs at earlier 
developmental stages or in aNSCs. Nevertheless, it is important to note that although 
they RAs and NSCs share many similarities, they exhibit as well fundamental differences. 
In the neurosphere assay, aNSCs show a greater stem cell capacity both on self-renewal 
and differentiation parameters (Sirko et al., 2009, 2013), and ultimately, aNSCs give rise 
to neurons in vivo, whereas reactive astrocytes do not. 
1.5 Mechanisms involved in the regulation of astrocyte 
reactivity 
Astrocytes are located in close contact to blood vessels and, therefore, are in an 
advantageous position to sense signals coming from the blood stream into the CNS. 
Molecules of different types and origins can play a role in triggering astrocyte activation. 
These molecules can activate astrocytes through 3 different ways: they could be present 
in the blood stream, be secreted within the CNS by endogenous cells, or be present in the 
cerebrospinal fluid (CSF) and enter the CNS through BBB disruption. 
Cytokines and growth factors get into contact with astrocytes either through the 
blood stream or through local paracrine secretion, and play a major role in astrocyte 
activation in CNS pathology. Among these types of molecules, epidermal growth factor 
(EGF), vascular endothelial growth factor (VEGF) and fibroblast growth factor 2 (FGF2) 
and transforming growth factor alpha and beta (TGFα, TGFβ), play major roles in 
astrocyte activation and regulation of functional properties of reactive astrocytes (Nieto-
Sampedro, 1988; Rabchevsky et al., 1998; Robel et al., 2011; You et al., 2017). EGF, VEGF 
and FGF2 are released by various cell types within the CNS upon damage, and they 
promote upregulation of their receptors. Activation of these growth-factor signaling 
pathways induces astrocyte proliferation through convergence on the mammalian target 
of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK) pathways 
(Codeluppi et al., 2009). VEGF also has an important role on BBB permeability (Chapouly 
et al., 2015), which can affect the interaction of astrocytes with other signaling molecules. 
These signaling pathways are also present in the adult neurogenic niches and regulate 
aNSC proliferation and survival (Robel et al., 2011).  
A key factor that has been shown to be of major importance for regulation of 
astroglial cell proliferation, both in the neurogenic niches, as well as in the damaged CNS 
is Sonic Hedgehog (SHH) (Amankulor et al., 2009; Pitter et al., 2014; Reinchisi et al., 
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2013). Astrocyte proliferation in the CNS parenchyma is only observed upon invasive 
injury with BBB disruption (Sirko et al., 2013), and it has been shown that SHH is 
upregulated and present in high levels in the CSF after injury. This suggests a possible 
molecular mechanism for activation of astrocyte proliferation in this type of injury, but 
the lack thereof in other types of CNS pathology in which the BBB is not disturbed (Sirko 
et al., 2013). 
Other factors that can trigger and modulate reactive astrogliosis are molecules or 
neurotransmitters that are locally released upon injury, such as reactive oxygen species 
(ROS), glutamate or ATP. These molecules are among the first and with strongest 
activation following injury, as they are released by damaged neurons or other cells 
(Sofroniew, 2009) 
In summary, reactive astrogliosis is a complex process that arises from the 
interaction of astrocytes with signals originated from different cell types within the CNS, 
but also from signals that are originated externally. This cross-talk leads to the activation 
of different signaling pathways, and ultimately, to changes in astrocyte transcriptional 
regulation, morphology and function. 
Now that the basic conceptual background and investigation approaches that are 
key to this study have been laid out, we can proceed to the specific questions addressed 
in this project. 
1.6 Astrogliosis and proliferation: can cortical reactive 
astrocytes self-renew in vivo? 
Although cortical reactive astrocytes can self-renew for many passages in vitro, in 
vivo they can divide only once. It remains however unknown whether astrocytes can be 
instructed to self-renew in vivo under different conditions. We therefore evaluated 
whether we could stimulate astrocytes to undergo more rounds of cell division and 
therefore enact their self-renewal potential in vivo if exposed to multiple pathological 
stimuli (see Section 1.9). 
Introduction 
22 
1.7 Environment-dependent plasticity of reactive astrocytes: 
can they give rise to neurons in a neurogenic environment? 
As we know that cortical reactive astrocytes exhibit stem cell potential and can 
give rise to neurons in vitro in the neurosphere assay, however remain within their 
lineage within their endogenous environment (Bardehle et al., 2013; Buffo et al., 2008), 
we questioned if this is a restriction that is intrinsic to these cells, or if it is rather a 
condition imposed by the environment in which they are located. 
It is known that the cortex, as well as all other regions of the brain excluding the 
neurogenic niches, is essentially gliogenic, and aNSCs heterotypically transplanted 
outside of the neurogenic niches give rise to glial cells only (Seidenfaden et al., 2006). 
Therefore, as for aNSCs, the lineage restriction observed in cortical reactive astrocytes 
may be limited by the local environment, and astrocytes might be able to give rise to 
other cell types when placed in more permissive environments, for example the adult 
neurogenic niches, or the developing embryonic brain. We therefore performed 
transplantation experiments where we relocated cortical reactive astrocytes to 
neurogenesis-permissive environment to evaluate if they could give rise to neurons in 
vivo under supportive conditions (see Section 1.9). 
1.8 Origin of neurosphere-forming cells isolated from lesioned 
cerebral cortex: local dedifferentiation or migration from 
SEZ aNSCs? 
As mentioned in previous sections, astrocytes from the cerebral cortex gray 
matter parenchyma become reactive following an invasive injury, de-differentiate, enter 
cell cycle and start to proliferate, and a subset of them shows stem cell potential in vitro 
(Buffo et al., 2008). The fact that parenchymal astrocytes go through cell division and 
generate progeny is undisputed, as this has even been even demonstrated through live in 
vivo imaging (Bardehle et al., 2013). 
However, in contrast to previous work from our group showing that astrocytes in 
the cortical gray matter acquire stem cell properties in vitro in response to an acute 
invasive injury (Buffo et al., 2008), recent evidence supports the idea that the 
neurosphere-forming astrocytes present in the cerebral cortex following ischemic stroke 
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are actually derived from aNSCs that migrate from the SEZ to the injury site (Faiz et al., 
2015).  
Since data gathered from different studies on in vitro and in vivo self-renewal and 
differentiation properties of SEZ aNSCs and cortical reactive astrocytes show evident 
differences between these two cell types (Shimada et al., 2012; Sirko et al., 2009, 2013), 
we investigated in our injury model whether the neurosphere forming cells in the injured 
cortex are indeed aNSCs migrating from the SEZ (and changing their properties on this 
migration) or are locally derived from resident parenchymal astrocytes (see Section 1.9). 
1.9  Aims 
The main goal of this project was to achieve a better comprehension about the 
stem cell potential that cerebral cortex reactive astrocytes acquire following invasive 
injury, and to functionally evaluate the extense of this acquired plasticity through several 
different approaches. The main rationale behind our investigation was that both aNSCs 
and cortical reactive astrocytes show stem cell potential in vitro, but however they do not 
enact this potential in vivo, where their behavior is much more restricted. We therefore 
evaluated how these cells would behave under different environmental cues. 
Firstly, as we know that cortical astrocytes do not divide in the healthy brain, but 
upon invasive injury proliferate and undergo maximally one cell division in vivo 
(Bardehle et al., 2013), and can self-renew for a long term in vitro (Figure 2) (Buffo et al., 
2008), we questioned whether these cels would also show self-renewal in vivo if they 
would be instructed to do so. For this end, we applied sequential pathological stimuli and 
evaluated astrocyte proliferation both through DNA labeling tools and clonal analysis to 
investigate if astrocytes could undergo more rounds of cell division in vivo (Figure 2, 
question I). 
Secondly, since astrocytes remain within their lineage in the cortex, but show the 
potential to generate neurons in vitro, we evaluated whether these cells could give rise to 
neurons in environments that support neurogenesis, namely the adult hippocampal 
neurogenic niche, and the embryonic developing brain (Figure 2, question II). 
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Figure 2. General aims of this PhD project. Parenchymal cortical astrocytes do not proliferate in 
the healthy brain, but upon invasive injury enter cell division and exhibit stem cell potential in 
vitro. As aNSCs show a big discrepancy between their potential in vitro and lineage in vivo, we set 
out to evaluate whether cerebral cortex reactive astrocytes could exhibit different stem cell 
hallmarks in vivo when exposed to different environmental cues. Our main questions in this 
project are outlined in the three question boxes below 
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Lastly, as neurospheres derived from injured cortex or SEZ tissue show very 
distinct potentials not only in vitro, but also in vivo through results we obtained within 
this project, we set out to confirm whether the recent claim that all neurospheres from 
the cortical injured tissue were generated by migrating aNSCs from the SEZ would still 
hold with further experiments (Figure 2, question III) 
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2 Material and Methods 
2.1 Solutions 
The composition of all solutions used in the different experiments within the 
scope of this work is given on the table below: 
Table 1. Composition and application of solutions used throughout experiments. 
Solution Composition Application 
DNA Lysis Buffer NaOH (0.5 M), NaCl (1.5 M) in H20 
DNA extraction 
(genotypings) 
TE Buffer Tris base (10 mM), EDTA (1 mM) in H2O (pH=8.0) 
DNA extraction 
(genotypings) 
PCR Buffer 10x 500 mM KCl, 100 mM Tris base in H2O (pH=8,7) 
PCR reaction 
(genotypings) 
Neurosphere Medium 1% penicillin-streptomycin, 1% supplement B27,  L-Glutamine 2 mM, 20 ng/ml EGF and FGF in DMEM/F-12 
Neurosphere assay  
(cell culture) 
Protease Inhibitor 
Solution 
Ovomucoid 1 mg/mL, 50 μg/mL bovine serum albumin 
and 40 μg/mL DNaseI in L-15 medium 
Neurosphere assay  
(cell culture) 
Differentiation 
Medium 
1% penicillin-streptomycin, 1% supplement B27, 
L-Glutamine 2 mM, 1% FBS in DMEM/F-12 
Differentiation assay  
(cell culture) 
Phosphate-Buffered  
Saline (PBS) 
Na2HPO4 x 2H20 (48 mM), KH2PO4 (272 mM),  
NaCl (137 mM), KCl (149 mM) in H20 (pH=7.4) 
Perfusion,  
immunostainings 
4% Paraformaldehyde  
(PFA) 
Na2HPO4 x 2H20 (133 mM), PFA (133.2 mM),  
32% NaOH to dissolve PFA in H2O (pH=7.4) 
Perfusion,  
immunostainings 
Krebs-Ringer-Hepes  
Buffer 
NaCl (125 mM), KCl (4.8 mM), CaCl2*2H2O (1.3 mM), 
MgSO4*7H2O (1.2 mM), KH2PO4 (1.2 mM),  
D-Glucose (5.6 mM) and HEPES (25mM) in H20 
Immunocytochemistry 
Sodium Tetraborate  
Buffer Na2B4O7 (0.1 M) in PBS (pH=8.5) Immunohistochemistry 
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Solution Composition Application 
Sodium Citrate  
Buffer 
C6H7NaO7 (0.01 M), Tween 20 (0.05%)  
in H2O (pH=6.0) 
Immunohistochemistry 
PO4 Buffer 
NaH2PO4*2H2O (0.6 M), NaOH (0.67 M)  
in H2O (pH=7.4) 
Preparation of  
storing solution 
Storage Solution Glycerol (30%), ethylenglycol (30%) in PO4 buffer (pH=7.4) 
Long-term storage  
of brain sections 
 
2.2 Experimental animals 
Female and male adult mice (2-3 months old) of the following lines were used: 
C57Bl6/J, double transgenic mice obtained from crosses between GLASTCreERT2 mice 
(Mori et al., 2006) and R26R-Confetti mice (Snippert et al., 2010) (referred to as 
GLAST/Confetti), homozygous knock-in CCR2RFP/RFP mice (Saederup et al., 2010) that 
result in a full knockout of the CCR2 gene (and therefore referred to as CCR2-/-), Aldh1l1-
eGFP OFC789Gsat (Gong et al., 2003) (referred to as Aldh1L1-eGFP), ACTB-eGFP (Okabe 
et al., 1997) (referred to as Actin-GFP), CAG-CAT-eGFP mice (Nakamura et al., 2006) 
(referred to as GFP-Reporter), and double transgenic mice obtained from crosses 
between Emx1Cre mice (Iwasato et al., 2000) and CAG-CAT-eGFP mice (Nakamura et al., 
2006) (referred to as Emx1-GFP). All mice were housed in a 12:12h light-dark cycle and 
were provided with food and water ad libitum. For experiments with Aldh1L1-eGFP mice 
also 20 months old mice were used. 
2.3 Genotypings 
All transgenic animals were genotyped before being used in the experiments. For 
Actin-GFP mice, genotyping could be performed via direct identification of GFP 
fluorescence in animals or tissue samples by use of a BlueStar Flashlight and VG-1 filter 
glasses (NIGHTSEA). For all other transgenic lines, genotyping was performed through 
standard polymerase chain reaction (PCR) and the following DNA purification and 
amplification protocols were used: 
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2.3.1 Tissue digestion and DNA extraction 
DNA extraction for genotyping was performed with technical support of Detlef 
Franzen. Firstly, either tail or ear clip samples were digested through incubation in 500 
µl lysis buffer (see Section 2.1) containing 5 µl of proteinase K (100 µg/ml of buffer, Sigma 
P2308) overnight at 50 °C in a shaker at 700 rpm. Samples were then centrifuged at 
12,000 rpm for 20 min at 4°C and the supernatant was transferred to a new tube. Next, 
500 µl of isopropanol were added to each tube and samples were gently mixed by 
inverting the tubes. Samples were then centrifuged for 20 min at 12,000 rpm at 4°C in 
order to pellet the DNA. Supernatant was discarded and open tubes were placed upside 
down to dry for 5 min. Finally, the DNA was dissolved in 100 µl TE buffer (see Section 2.1) 
and incubated at 50°C for 30 min at 700 rpm. Samples were kept at 4°C until further 
processing.  
2.3.2 Polymerase chain reaction 
Standard polymerase chain reaction (PCR) was performed under specific 
conditions for each mouse line. The primers, reagent mix and PCR cycle conditions used 
for genotyping each mouse line are listed in detail below: 
Table 2. Primers used for genotyping. 
Mouse line Gene Primer ID Sequence 
GLAST/Confetti 
GLASTCreERT2 
Primer F8 GAG GCA CTT GGC TAG GCT CTG AGG A 
Primer R3 GAG GAG ATC CTG ACC GAT CAG TTG G 
Primer CER1 GGT GTA CGG TCA GTA AAT TGG ACA T 
Rosa26 confetti  
mutant 
Rosa26 confetti F GAA TTA ATT CCG GTA TAA CTT CG 
Rosa26 confetti R AGA GTA TAA AAC TCG GGT GAG C 
Rosa26 WT 
Rosa26 WT F CTC CTG GCT TCT GAG GAC C 
Rosa26 WT R CCA GAT GAC TAC CTA TCC TC 
CCR2RFP/RFP CCR2 
CCR2 F TAA ACC TGG TCA CCA CAT GC 
CCR2 WT R GGA GTA GAG TGG AGG CAG GA 
CCR2 mut R CTT GAT GAC GTC CTC GGA G 
Emx1-GFP 
Emx1-Cre 
Cre F GTG AGT GCA TGT GCC AGG CTT 
Cre R TGG GGT GAG GAT AGT TGA GCG 
Test Cre GCG GCA TAA CCA GTG AAA CAG 
CAG-CAT-eGFP 
AG-2 CTG CTA ACC ATG TTC ATG CC 
CAT-2 GGT ACA TTG AGC AAC TGA CTG 
 
  
Material and Methods 
30 
Table 3. PCR solution mix for each gene. 
 
GLASTCreERT2 Rosa26 confetti 
Rosa26 
WT CCR2 
Cre 
mutant Cre WT eGFP 
H2O 10 µl 19.8 µl 19.8 µl 10.5 µl 13.3 µl 13.3 µl 12 µl 
25 mM 
MgCl 2.5 µl     2.5 µl     1.5 µl 
Buffer (10x) 2.5 µl 2.5 µl (*) 2.5 µl (*) 2.5 µl 2.5 µl (*) 2.5 µl (*) 2.5 µl 
Primer 1 F8: 1 µl F: 0.5 µl  F: 0.5 µl F: 0.5 µl Cre F: 1 µl Cre F: 1 µl AG-2: 1 µl 
Primer 2 R3: 0.5 µl R: 0.5 µl R: 0.5 µl WT R: 0.5 µl Cre R: 1 µl Test Cre: 1 µl CAT-2: 1 µl 
Primer 3 CER1: 0.5 µl      mut R: 0.5 µl       
Q-Solution 5 µl     5 µl 5 µl 5 µl 5 µl 
dNTPs 0.5 µl 0.5 µl 0.5 µl 0.5 µl 0.5 µl 0.5 µl 0.5 µl 
Taq 0.5 µl 0.2 µl (*)  0.2 µl (*) 0.5 µl 0.2 µl (*) 0.2 µl (*) 0.5 µl 
DNA 2 µl 1 µl 1 µl 2 µl 1 µl 1 µl 1 µl 
End volume 25 µl 25 µl 25 µl 25 µl 25 µl 25 µl 25 µl 
 (*) Reagents from QIAGEN Taq DNA Polymerase kit (Cat No. 201203). 
In every PCR batch we included a positive control (previously verified DNA 
sample), a negative control (wildtype DNA sample) and a DNA-free control (with water 
instead of DNA). These controls were used for the analysis of the results and to rule out 
any contaminations in the reaction. 
Table 4. Thermocycler conditions for each PCR reaction. 
 
GLASTCreERT2 Rosa26 confetti Rosa26 WT CCR2 Cre mutant Cre WT eGFP 
Initialization 94°C, 5' 95°C, 5' 95°C, 5' 94°C, 2' 94°C, 5' 94°C, 5' 95°C, 5' 
X cycles 35 X 35 X 35 X 10 X 36 X 36 X 30 X 
    i) Denaturation 94°C, 30'' 95°C, 30'' 95°C, 30'' 94°C, 30'' 94°C, 30'' 94°C, 30'' 95°C, 30'' 
    ii) Annealing 56°C, 40'' 60°C, 30'' 60°C, 30'' 65°C, 30'' 64°C, 1' 64°C, 1' 55°C, 30'' 
    iii) Elongation 72°C, 40'' 72°C, 45'' 72°C, 45'' 72°C, 30'' 72°C, 30'' 72°C, 30'' 72°C, 1' 
X cycles 
   
25 X 
   
    i) Denaturation 
   
94°C, 30'' 
   
    ii) Annealing 
   
52°C, 30'' 
   
    iii) Elongation 
   
72°C, 30'' 
   
Final elongation 72°C, 5' 72°C, 7' 72°C, 7' 72°C, 2' 72°C, 5' 72°C, 5' 72°C, 10' 
Final hold 4°C, ∞ 4°C, ∞ 4°C, ∞ 4°C, ∞ 16°C, ∞ 16°C, ∞ 4°C, ∞ 
Material and Methods 
31 
2.3.3 Gel electrophoresis 
10 µl of each PCR product were ran at 100-120V for approximately one hour in 
2% agarose gel containing ethidium bromide or SYBR Safe for visualization of DNA 
bands. Detection of DNA bands was performed with UV-light. 
2.4 Tamoxifen induction 
GLAST/Confetti mice received in total 3 intraperitoneal (i.p.) injections of 80 µg 
tamoxifen per gram of body weight (stock solution: 20 mg/ml tamoxifen in corn oil with 
10% ethanol mixed by sonication for 15 min), which were delivered every other day 
within the period of 5 days. After the last tamoxifen injection there was a waiting period 
of 7 days before an injury was performed. 
2.5 Surgical procedures 
All surgical procedures were performed in compliance with animal welfare 
policies and approved by the Government of Upper Bavaria under the license numbers 
55.2-1-54-2532-171-2011 and 55.2-1-54-2532-210-2016. 
All mice undergoing surgery were anesthetized with an intraperitoneal injection 
of midazolam (5 mg/kg of body weight), medetomidine (0.5 mg/kg) and fentanyl (0.05 
mg/kg). Bepanthen (Bayer) was administered to the eyes to prevent dryness and 
damage. Animals undergoing surgical procedures in the brain were shaved on the top of 
the head and, after fixing the mouse to a stereotactic apparatus, an incision was made on 
the head and lidocain gel 2% was applied on the skull surface briefly for local anesthesia. 
Next, the procedure for each type of surgery was performed as described in detail below. 
At the end of all surgical procedures, anesthesia was antagonized with an i.p. injection of 
atipamezol (2.5 mg/kg), flumazenil (0.5 mg/kg) and buprenorphine (0.1 mg/kg), and 
animals were left to recover on a heating pad until they were fully awake. Meloxicam (1 
mg/kg) was administered as a postoperative analgesic for 3 days following surgery.  
2.5.1 Stab wound lesion 
A unilateral craniotomy was performed between bregma and lambda cranial 
sutures to expose the surface of the brain. Stab wound (SW) was inflicted by inserting a V 
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lancet-shaped knife (19 gauge, Alcon) into the somatosensory cortex gray matter using 
the following coordinates from bregma:  
Medio-lateral (x): between +1.8 and +2.0 mm 
Antero-posterior (y): from -0.8 to-2.0 mm 
Dorso-ventral (y) (from the surface of the brain): -0.6 mm  
The craniotomy was covered once more with the skull flap and the skin was 
sutured. For animals in repetitive lesions experiments the second injury was performed 
either 5 days (for neurosphere culture experiments) or 14 days (for all other 
experiments) after the first one in the same manner and on the same location. This was 
achieved with high precision by following the coordinates and by using recorded 
information of blood vessels as landmarks to assist on recognizing the injury site. For 
neurosphere assay experiments, animals were sacrificed 5 days after the last injury, 
which is the time point where astrocyte proliferation in vivo reaches its peak and 
neurosphere culture yields the greatest number of spheres. In all other SW experiments 
animals were sacrificed 24 days after the first lesion for the analysis of BrdU and EdU 
cells labeled in vivo. 
2.5.2 Transplantation in adult mice 
For analysis of the differentiation potential of reactive astrocytes and aNSCs in 
the neurogenic niches of the adult murine brain, we transplanted neurosphere-derived 
cells from the injured cortex and SEZ of actin-GFP mice into the SEZ and DG of adult 
C57Bl6/J mice. Firstly, coordinates for transplantation sites were taken with a Hamilton 
syringe and a superficial and small hole was drilled on the skull above each 
transplantation site. The dura was perforated with a syringe and cells were transplanted 
into both neurogenic niches using the following coordinates from bregma:  
SEZ:  
Medio-lateral (x): ±1.2 mm 
Antero-posterior (y): +0.7 mm 
Dorso-ventral (z) (from the surface of the brain): -from -1.9 to -1.7 mm  
DG:  
Medio-lateral (x): ±1.6 mm 
Antero-posterior (y): -2.0 mm 
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Dorso-ventral (z) (from the surface of the brain): -from -2.1 to -1.9 mm  
A total of 15,000 donor cells in a 1 µl volume were transplanted into each site. 
The cell suspension was injected with a Hamilton syringe (33 gauge) and distributed 
dorso-ventrally over 300 μm in 3 injection points. To have an internal control for our 
experiments, cells coming from both sources (injured cortex and SEZ) were always 
transplanted in the same animal, but in different brain hemispheres. Transplanted 
animals were perfused at 2 or 4 weeks post transplantation (wpt) for 
immunohistochemical analysis of cell differentiation. 
2.5.3 Transplantation in E13 embryos 
All embryo transplantations were performed by Dr. Sven Falk. Briefly, timed 
pregnant females at E13 stage were anaesthetized as described above and fixed to a 
heating pad covered with a sterile diaper pad. Females were fixed to the pad with tape, 
the abdominal fur was cleared out with hair removal cream and an incision was made on 
the abdomen, through which the uterine horns containing embryos were exposed. 
Embryos were kept hydrated with sterile PBS while exposed out of the body cavity. Cell 
suspensions were mixed with FastGreen FCF 1% w/v and injected with a glass capillary 
though the uterine wall into the lateral ventricle of the developing embryo brains. A total 
of 6 embryos were injected per surgery, and for each pregnant female, cells from only 
one source (either injured cortex or SEZ) were used for injections. After completion of 
injections, the uterine horns were carefully returned to the body cavity, and both the 
muscle layer and the skin were sutured. Anesthesia was antagonized as described above. 
Transplanted animals were perfused at 2 or 4 wpt (at P7 and P21 developmental stages) 
for immunohistochemical analysis of cell differentiation. 
2.5.4 Virus injections 
For analysis of the origin of neurosphere forming cells isolated from cortical 
tissue, we injected viruses on the somatosensory cortex gray matter to label resident 
cells and latter performed SW surgery, followed by neurosphere assay with tissue from 
the injured cortex. 
Viral injections were performed unilatery at the following coordinates from 
bregma:  
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Medio-lateral (x): +2.0 mm 
Antero-posterior (y): -1.4 mm 
Dorso-ventral (z) (from the surface of the brain): between -0.7 and -0.5 mm  
A small and superficial hole was drilled following the coordinates, and a volume 
of 0.5 to 1 µl of virus was injected with a glass capillary at a rate of 30 nl/min. 
Viral production was performed with technical support of Ines Mühlhahn and Dr. 
Chulan Lao. The following viruses were used for these experiments: 
i. AAV-gfaABC1D-tdTomato (referred to as AAV-tdTomato) (Shigetomi et al., 
2013) 
ii. (rAAV2/5) pAAV-gfaABC1D-iCre (referred to as AAV-iCre) (Druckmann et al., 
2014) 
After undergoing viral injection, animals were either perfused 3 weeks later for 
immunohistochemical analysis of cell labeling in the uninjured brain, or underwent SW 
surgery 2 weeks after injection. In the latter case, animals were either perfused for 
immunohistochemical analysis or had live tissue isolated for neurosphere assay 
experiments at 5 days post injury. 
2.6 BrdU and EdU labeling 
5-bromo-2'-deoxyuridine or BrdU (Sigma) and 5-ethynyl-2'-deoxyuridine or EdU 
(Thermo Fisher) are thymidine analogues that get incorporated into the cell’s DNA upon 
replication and therefore were used to label proliferating cells. BrdU and EdU were 
administered to the animals via drinking water containing 1% sucrose at a concentration 
of 1 mg/ml and 0.2 mg/ml, respectively. In all animals used for immunostaining analysis, 
BrdU water was administered for the first 10 days after SW, followed by a 4-day washout 
period in which animals only received regular water, followed once more by a 10-day 
labeling period in which animals received EdU water. Exceptions to this protocol were 
performed in experiments designed as controls for BrdU/EdU labeling and detection. To 
check for specificity of BrdU and EdU detection and rule out the existence of cross-
reactivity of antibodies and chemical reaction detection methods, animals received either 
BrdU or EdU in drinking water for 5 days, or BrdU and EdU sequentially in drinking 
water, each for 5 days. To check whether there were differences in the sensitivity of 
detection or in the incorporation of both thymidine analogues, an animal received both 
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BrdU and EdU combined in drinking water for 5 days. To analyze whether the order of 
delivery of the thymidine analogues could have an effect in their incorporation, an animal 
was given BrdU and EdU water in an inverse order (EdU water in the first, and BrdU 
water in the second time frame). Finally, to investigate whether the interaction between 
both thymidine analogues could have toxic effects on the cells, a group of animals 
received only BrdU water for both time frames. 
2.7 Neurosphere culture 
2.7.1 Neurosphere assay 
Animals were sacrificed by cervical dislocation and brains were collected in ice-
cold Hank’s Balanced Salt Solution (HBSS, Thermo Fisher) buffered with 10mM HEPES 
(Thermo Fisher). Tissue from intact and injured somatosensory gray matter was isolated 
by removing an area of 1.25 mm in radius from the lesion site with a punch and 
subsequently removing the remaining white matter and meninges with a forceps. Tissue 
from SEZ was isolated by separating both brain hemispheres with a sagital cut using a 
scalpel, and accessing the lateral ventricule wall by removing the hippocampus with a 
fine forceps. A thin layer of anterior SEZ tissue was then dissected with the forceps. All 
samples were immediately immersed in 0.5 to 1 ml neurosphere medium (see Section 
2.1) (all components from Thermo Fisher) after collection. Samples were gently 
mechanically dissociated and subsequently digested with Trypsin (0.025%) (Thermo 
Fisher) for 20 min at 37 °C and enzymatic digestion was stopped with a protease 
inhibitor solution (see Section 2.1) (all components from Sigma, except for DNaseI from 
Worthington). Cells were centrifuged at 1500 rpm for 5 min, resuspended in 
neurosphere medium containing FGF-2 and EGF growth factors and plated at a density of 
5 cells/µl in 24-well cell culture plates for neurosphere quantification or in 25cm² 
culture flasks for growing neurospheres for transplantation. Neurospheres were 
quantified at 14 days in vitro (div). To assess self-renewal, neurospheres were 
subsequently passaged and quantified. Neurosphere suspensions were collected and 
centrifuged for 5 min at 1500 rpm and resuspended in Trypsin (0.125%) (Thermo 
Fisher) and incubated for digestion at 37°C for 15 min. Cells were then processed in the 
same way as described above. 
For dissection of cortical tissue of GFP-Reporter mice injected with AAV-iCre, 
only the tissue with GFP expression was extracted. This was performed via direct 
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identification of GFP fluorescence in the brain by use of a BlueStar Flashlight and VG-1 
filter glasses (NIGHTSEA) during dissection. 
2.7.2 Differentiation assay 
To assess the differentiation potential of neurospheres, these were picked with a 
20 µl pipette and plated on glass coverslips previously coated with 100 µg/ml poly-L-
ornithine (Sigma) and 20 µg/ml laminin (Roche). The neurospheres were kept for 7 days 
in differentiation medium (see Section 2.1) containing 1% fetal bovine serum (PAN-
Biotech) and in the absence of growth factors, and were analyzed via 
immunocytochemistry for the determination of neurosphere cell composition. 
2.7.3 Dissociation of neurospheres for transplantation 
Single cell suspensions for transplantation experiments were prepared from 
neurosphere cultures from the injured cortex and SEZ cultured 14 div. First, the entire 
content of the culture flasks (5 mL per flask) was transferred to 15 ml Falcon tubes and 
centrifuged for 5 min at 1500 rpm. The supernatant was discarded and cells were 
resuspended in 500 µl Trypsin (0.0625%). Cells from the SEZ were incubated for 8 min at 
37°C, and cells from the injured cortex for 15 min. Digestion was stopped by addition of 1 
ml of protease inhibitor solution (see Section 2.1), for 5 min at room temperature. Cell 
suspensions were centrifuged for 4 min at 800 rpm, the supernatant was discarded and 
cells were resuspended and counted on the Neubauer chamber with addition of 1:1 
trypan blue. Cell suspensions were transferred to 0.5 ml Eppendorf tubes and 
centrifuged for 5 min at 1000 rpm. Finally, the supernatant was discarded and each cell 
pellet was resuspended in a calculated volume of neurosphere medium to achieve an end 
single cell suspension of 15,000 cells/µl. 
2.8 Immunocytochemistry 
After 7 days of differentiation, neurospheres were incubated in Krebs-Ringer-
Hepes Buffer (see Section 2.1), containing 0.1% bovine serum albumin (Sigma) for 5 min, 
followed by incubation with mouse IgM anti-O4 antibody for 20 min, washing and 
subsequential fixation with PFA 4% (see Section 2.1) for 5 min. Neurospheres were then 
incubated with mouse IgG2b anti-βIII-tubulin and rabbit anti-GFAP primary antibodies 
for 20 min, followed by washing and incubation with species- and subclass-specific 
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fluorophore-coupled secondary antibodies (1:500) for 20 min, and lastly, incubated for 5 
min with DAPI (1:10,000, Sigma, D9542) for nuclear labeling and mounted on glass slides 
with Aqua-Poly/Mount (Polysciences). Detailed information of all primary antibodies 
used for immunocytochemistry of differentiated neurospheres is listed on the tables 
below: 
Table 5. Primary antibodies used for immunocytochemistry. 
Antigen / clone Host / isotype Dilution Company Catalogue number 
ß III Tubulin  mouse IgG m2b 1:250 Sigma T8660 
O4 mouse IgM 1:50 Sigma O7139 
GFAP rabbit 1:500 Agilent (Dako) Z0334 
2.9 Perfusion and brain sectioning 
Mice were deeply anesthetized with an intraperitoneal injection of ketamine 100 
mg/ml and 2% xylazin (0.01 ml/g body weight) and transcardially perfused with ice-cold 
PBS (see Section 2.1) followed by 4% PFA (see Section 2.1) for 20 min each. Stab wound-
injured wildtype (WT) and CCR2-/- mice brains were post-fixed in 4% PFA for 2 h and 
incubated in sucrose 30% in PBS overnight for dehydration and cryoprotection. These 
brains were sectioned with the cryostat in 40 µm thick coronal slices. Brains from 
GLAST/Confetti mice and C57Bl6/J from transplantation experiments were post-fixed in 
4% PFA overnight, embedded in 4% agarose blocks and sectioned in 60 µm thick slices in 
the vibratome. GLAST/confetti brains were sectioned coronally and transplanted 
C57Bl6/J brains were sectioned sagitally. All sections were kept in free floating for 
further processing. For long-term preservation, sections were kept in storage solution 
(see Section 2.1) and maintained at -20°C. 
2.10 Immunohistochemistry and EdU detection 
Sections were blocked and permeabilized by incubation in PBS (see Section 2.1) 
containing 0.5% TritonX-100 (Sigma) and 10% normal goat serum (Thermo Fisher) for 1 
h at room temperature. EdU detection was then performed with the Click-iT Edu Alexa 
Fluor 647 Imaging Kit (Thermo Fisher, C10340), by incubation with the reaction mix for 
45 min at room temperature. EdU detection was always performed before incubation 
with all other antibodies, except for when combined with GFP immunohistochemistry 
(GLAST/Confetti clonal analysis experiment), in which case EdU detection was 
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performed afterwards (following manufacturer’s instructions). Immunohistochemistry 
was carried out using the following primary antibodies, which were incubated overnight 
on a tabletop shaker at 4°C for 40 µm thick sections and over two nights for 60 µm thick 
sections:  
Table 6. Primary antibodies used for immunohistochemistry. 
Antigen / clone Host / isotype Dilution Company Catalogue no. Pre-treatment 
ACSBG1 rabbit 1:350 Abcam ab65154   
Aldh1L1  mouse IgG1k 1:200 Merck/Millipore MABN495 citrate 96°C 20 min 
BrdU BU1/75 rat 1:200 Biozol BZL20630 citrate 96°C 20 min 
BrdU BU-33 mouse IgG1 1:200 Sigma B2531 HCl 2N at RT 30 min 
CD31 rat 1:50 BD / Bioscience 550274   
DCX guinea pig 1:200 Merck/Millipore AB2253   
GFAP rabbit 1:250 Agilent (Dako) Z0334   
GFAP  mouse IgG1 1:500 Sigma G3893   
GFP chicken 1:400 Aves Labs GFP-1020   
Iba1 rabbit 1:500 Wako 019-19741   
Ki67 rat 1:300 Agilent (Dako) M7248   
NeuN mouse IgG1 1:250 Merck/Millipore MAB377   
NG2 rabbit 1:400 Merck/Millipore AB5320    
Olig2 rabbit 1:250 Merck/Millipore AB9610   
RFP rabbit 1:500 Rockland 600-401-379   
S100ß rabbit 1:250 Sigma S2644    
 
Next, sections were washed in PBS and incubated with species- and subclass-
specific secondary antibodies used at 1:500 and incubated on a tabletop shaker for 3 h at 
room temperature. Finally, all sections were incubated for 15 min with DAPI (1:1000, 
Sigma, D9542) for nuclear labeling and mounted on glass slides with Aqua-Poly/Mount 
(Polysciences). 
2.10.1 DNA denaturation with hydrogen chloride 
For specific BrdU immunohistochemistry (without cross-reactivity with EdU), 
sections were firstly immunostained with antibodies for other antigens (e.g. GFAP, Iba1, 
NG2), as well as stained for EdU before acid treatment for DNA denaturation. Sections 
were fixed with 4% PFA (see Section 2.1) for 10 min, washed with PBS and incubated 
with 2N HCl for 30 min at room temperature on a tabletop shaker. Next, sections were 
incubated in sodium tetraborate buffer 0.1 M (see Section 2.1) for 30 min, washed, and 
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immunohistochemistry was performed with mouse IgG1 anti-BrdU clone BU33 and 
secondary antibody to mouse IgG1 Alexa Fluor 555 as described above.  
2.10.2 Antigen retrieval with citrate treatment 
For immunohistochemistry using the mouse IgG1k anti-Aldh1L1 or rat anti-BrdU 
clone BU1/75 (which detects both BrdU and EdU) antibodies, sections underwent citrate 
treatment for antigen retrieval. For this end, immunohistochemistry was performed with 
other antibodies (e.g. GFP, RFP, GFAP) as described above and sections were fixed with 
4% PFA for 10 min, washed and then incubated in 0.01 M sodium citrate buffer (see 
Section 2.1) for 20 min at 96 °C in a dry bath. Sections were then washed in PBS and 
incubated with mouse IgG1k anti-Aldh1L1 or rat anti-BrdU clone BU1/75 and respective 
species- and subclass-specific fluorophore-coupled secondary antibodies as described 
above. 
2.11 Confocal microscopy 
Images were acquired using a laser-scanning confocal microscope (Zeiss, LSM 
710), and analyzed with ImageJ 1.49g software. Immunohistochemistry quantifications 
were performed with the Cell Counter plug-in for Image J 1.49g, by careful inspection 
across serial optical sections (spaced at 1.5 μm) of confocal Z-stacks acquired with a 25× 
or 40× objective. 
2.12 Purification of cells using Fluorescence-Activated Cell 
Sorting 
Cells from young (2 months-old) and old (20 months-old) injured Aldh1l1-eGFP 
mice were dissociated at 5 dpi from the grey matter of the somatosensory cortex using 
the same procedure as described above for the neurosphere culture. Following 
dissociation, cells were resuspended in neurosphere medium lacking growth factors (see 
Section 2.1) and filtered with a 40 µm strainer. Prior to sorting, cell viability of a wild type 
sample processed in parallel was determined via staining with propidium iodide (1:1000, 
Sigma). Aldh1l1-eGFP+ cells were isolated by fluorescence-activated cell sorting 
(FACSAria, BD) with a 488 nm laser and 530/30 BP filter. Gating parameters were set by 
side and forward scatter to eliminate debris and aggregated cells. Gating settings for GFP 
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fluorescence were set with a WT sample processed in parallel. Cells were sorted into 
RNAse-free eppendorfs containing RLT buffer with 1% ß-mercaptoethanol and further 
processed for qPCR analysis. 
2.13 RNA extraction and quantitative RT-PCR 
RNA from FACS-sorted cells was extracted with the RNeasy Plus Micro Kit 
(QIAGEN) according to manufacturer’s instructions, and genomic DNA was removed via 
enzymatic reaction. The extracted RNA was then retro-transcribed with SuperScriptIII 
Reverse Transcriptase and Random Primers (Roche). Quantitative qPCR was performed 
on a LightCycler480 (Roche) with the LightCycler Probe Master kit (Roche) and 
Monocolor Hydrolysis Probe (Roche), and all solutions were prepared according to 
manufacturer’s instructions. The expression of each gene was analyzed in technical 
triplicates per biological sample. Each biological sample consisted on a pool of cells from 
3 animals per age-group. Data was processed with the ΔΔCt method (Livak and 
Schmittgen, 2001). Detailed information about the primers and probes used for the qPCR 
is listed in the table below: 
Table 7. Primers and probes used for qPCR analysis. 
Gene Access number Primer Forward Primer Reverse UPL 
HRPT NM_013556.2 tcctcctcagaccgctttt cctggttcatcatcgctaatc 95 
Ccdn1 NM_007631.2 gagattgtgccatccatgc ctcctcttcgcacttctgct 67 
GFAP NM_010277.3 acagactttctccaacctccag ccttctgacacggatttggt 64 
Ptch1 NM_008957.2 ggaaggggcaaagctacagt tccaccgtaaaggaggctta 56 
Smo NM_176996.4 gcaagctcgtgctctggt gggcatgtagacagcacaca 3 
2.14 Statistical analysis 
Statistical analysis was performed using PRISM (Graphpad, v5.03). Appropriate 
statistical tests were chosen depending on sample size, data distribution and number of 
comparisons. All data consisting of two groups (e.g. WT mice, single versus repetitive 
injuries) were analyzed with the non-parametric Wilcoxon-Mann-Whitney test. For 
comparisons of more than 2 groups (WT and CCR2-/- on both injury conditions, as well as 
data from neurosphere cultures), analysis was performed with one-way ANOVA and non-
parametric Dunn’s post-hoc test. The minimum level of significance was defined as 
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P < 0.05 and all values in dot plots are reported as median ± interquartile range (IQR), 
and values in pie charts are reported as mean ± standard deviation (SD). Image 
processing was performed with ImageJ and Adobe Illustrator CS6 (Adobe Systems) for 
preparation of multipanel figures. 
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3 Results 
3.1 Modulation of the proliferative behavior of reactive 
astrocytes via repetitive pathological stimuli 
3.1.1 Thymidine analogue-based analysis of cell proliferation following 
repetitive injuries: dual-labeling with BrdU and EdU 
In order to assess whether and to which extent a larger number of astrocytes in 
vivo could be stimulated to proliferate, and, in particular, whether the same astrocytes 
may proliferate several times or self-renew, we analyzed the acquisition of cycling 
activity of reactive astrocytes in response to a repetitive pathological event in the adult 
cerebral cortex gray matter. For this purpose, we used a dual-labeling strategy to follow 
cycling cells during S-phase in vivo by combining two thymidine analogues, 5-bromo-2'-
deoxyuridine (BrdU) and 5-ethynyl-2'-deoxyuridine (EdU) at different time periods after 
SW injury in the somatosensory cortex gray matter. 
Thymidine analogues have been long used as a tool to study cell proliferation, and 
were particularly valuable for early studies providing evidence for adult mammalian 
neurogenesis (Altman, 1962; Altman and Das, 1965). This tool works on the basis that 
cells incorporates thymidine analogues indiscriminately into the DNA upon synthesis and 
the correlation between analogue incorporation and cell cycling activity has been 
confirmed by co-labeling with other known mitotic markers, such as Ki-67 (Kee et al., 
2002). Therefore, this tool allows one to label cells that were mitotically active on the 
time point during which the analogue was at the cell’s disposal.  
As our goal in this study was to analyze the dynamics of astrocyte proliferation 
following multiple injuries, we took advantage of the distinct properties of the two 
thymidine analogues we used in order to develop an experimental paradigm that would 
allow us to answer our scientific questions. Both analogues - BrdU and EdU - can be 
detected separately through antibody binding and a chemical reaction, respectively. In 
order to effectively use this dual-labeling method to define the cycling activity of reactive 
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astrocytes according to the time frame of BrdU and/or EdU incorporation it is essential 
to be able to detect each of the analogues in a precise manner. 
We had to first establish this dual labeling method in our experimental setting, 
and therefore it was crucial to ascertain we could effectively and reliably label and detect 
the cells within the paradigm. 
To check for specificity of BrdU and EdU detection and rule out the cross-
reactivity of antibodies and chemical reaction detection methods, we performed 
immunohistochemical analysis and stainings in coronal sections of animals that received 
BrdU and/or EdU in drinking water and analyzed the labeling of cells in the SEZ, a region 
with abundant proliferative activity in the adult murine brain (Figure 3A). More 
specifically, we analyzed if EdU chemical reaction could detect BrdU-labeled DNA and if 
BrdU antibody could detect EdU-labeled DNA (Figure 3B). 
In animals that received only one of the analogues in drinking water we could not 
identify any cross-reactivity on the detection of the other analogue, being it BrdU or EdU 
(Figure 3C,D). Furthermore, when we delivered BrdU and EdU sequentially in drinking 
water we could identify cells that were single labeled (BrdU+ or EdU+) and also double 
labeled cells (BrdU+/EdU+) (Figure 3E), indicating that our labeling and detection 
protocols are suitable for tracing cell proliferation to a precise temporal frame of BrdU 
and EdU delivery.  
In order to evaluate if the incorporation affinity and detection of both thymidine 
analogues were comparable, we analyzed the pattern of labeled cells in the SW lesion of 
the cortical gray matter of an animal that received both BrdU and EdU combined in 
drinking water after SW injury (Figure 4A,B). Immunohistochemical quantitative analysis 
indicated that, regardless of cell type, the vast majority of proliferating cells in the lesion 
area were double labeled (BrdU+/EdU+), indicating no difference in BrdU and EdU 
incorporation as well as sensitivity of the detection methods used (Figure 4C). 
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Figure 3. Specific detection of cycling cells using dual-labeling of BrdU and EdU in vivo. (A) 
Controls for cross-reactivity in BrdU/EdU detection were performed in coronal sections of the 
SEZ, a region with abundant proliferative activity. (B) BrdU and EdU are thymidine analogues that 
get incorporated into the DNA upon replication and can be detected via antibody 
immunohistochemistry and fluorophore labeling via chemical reaction, respectively. We 
investigated whether EdU detection reaction could bind to BrdU-labeled DNA (c) or vice-versa (d). 
(C) EdU detection reaction did not cross-react with BrdU in an animal that received only BrdU in 
drinking water, and (D) BrdU antibody did not bind to EdU in a mouse that received only EdU. (E) 
When BrdU and EdU were delivered sequentially, we could identify cells that were single labeled 
for BrdU+ (red arrowheads) or EdU+ (green arrowheads), and double labeled BrdU+/EdU+ cells 
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(yellow arrowheads). Scale bars represent 100 µm and 10 µm on inlays. LV: lateral ventricle, CC: 
corpus callosum, Str: Striatum. 
To analyze whether the order of delivery of the thymidine analogues could have 
an effect in their incorporation into the DNA, an animal was delivered BrdU and EdU 
water in an inverse order (EdU water in the first, and BrdU water in the second time 
frame), and the number of labeled cells was similar regardless of the order of BrdU/EdU 
delivery (Figure 4D,E,G). Lastly, to investigate whether the interaction between both 
thymidine analogues could have toxic effects on astroglial cells (GFAP+) that incorporate 
them, a group of animals received only BrdU water for both time frames, and showed 
similar numbers of labeled cells than the animals that received both thymidine analogues 
in a sequential manner (Figure 4F,G). 
Altogether, we could confirm that our dual-labeling method based on BrdU and 
EdU thymidine analogue delivery is a good tool to investigate the dynamics of the 
astrocyte proliferative pool following injury, since both analogues can be identified in a 
precise and reliable manner, which allows us to trace the injury-induced proliferative 
response of cells in a temporally defined manner. 
 
Results 
47 
 
Figure 4. BrdU and EdU have similar incorporation profiles and detection sensitivity. (A) 
We analyzed BrdU and EdU incorporation in coronal sections of the injured somatosensory cortex. 
(B) When BrdU and EdU were administered together in drinking water there were no major 
differences in their detection sensitivity. (C) When both analogues were delivered together in 
drinking water, quantifications depict that the majority of detected proliferating cells were 
double-labeled (BrdU+/EdU+), both in the total and also within the astrocytic population (GFAP+). 
(D,E) Administration of BrdU and EdU in different sequential orders yielded similar results in the 
detection of proliferating astrocytes. (F) Administration of BrdU in both time periods yielded a 
similar labeling pattern, suggesting a lack of toxicity effects that could arise from the 
incorporation of two different thymidine analogues by proliferating cells. (G) Quantifications of 
the three different BrdU/EdU administration paradigms show comparable numbers of labeled 
cycling astrocytes (GFAP+ proliferating cells). Data is depicted as mean ± SD. Scale bars represent 
100 µm. Yellow dashed line indicates the lesion site. SW: stab wound lesion, Ctx: cortex. 
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3.1.2 Repetitive injuries induce changes in the proliferative repertoire 
of cortical gray matter astrocytes 
In order to investigate whether parenchymal astrocytes were able to self-renew 
in vivo or if we could modulate a change in the proliferative behavior of the astrocytic 
pool, we decided to provide stimuli that are known to trigger astrocyte proliferation, 
namely the SW lesion. To challenge and boost proliferative response in these cells, we 
delivered two SW lesions sequentially into the same location in order to stimulate a 
certain population of astrocytes with both lesions. We compared the results to single-
lesioned animals in order to analyze changes in astrocyte proliferation in response to the 
second lesion. 
To analyze the cycling activity of cortical gray matter astrocytes in response to 
single or repetitive injuries, we delivered BrdU and EdU in separate time frames 
following lesion and performed a pulse-chase analysis. In this way, we were able to 
characterize the proliferative profile of astrocytes according to their temporal 
proliferation pattern (Figure 5A). More specifically, we could identify different subsets of 
proliferative astrocytes according to the time frame in which they went through cell 
division (BrdU+, EdU+ or BrdU+/EdU+ labeled cells) (Figure 5A). 
Quantitative analysis of reactive astrocytes (GFAP+ cells) around the lesion site 
surprisingly showed that the total numbers of reactive astrocytes were similar after 
single or repetitive injuries, suggesting the existence of a mechanism for restoration and 
maintenance of the astrocytic population at homeostatic numbers following multiple 
injuries (Figure 5B).  
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Figure 5. Repetitive injuries induce changes in astrocyte proliferative behavior. (A) The 
experimental paradigm used to analyze astrocyte proliferation in response to single and multiple 
pathological stimuli consisted on sequential BrdU and EdU labeling with long-term detection of 
cycling cells. This paradigm allowed us to detect 3 different groups of cycling cells according to the 
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time of proliferation (BrdU+, EdU+ and BrdU+/EdU+). (B) Numbers of total and proliferating 
reactive astrocytes (GFAP+ cells) on the lesion site were similar on both injury conditions. (C) 
Repetitive injuries led to an increase in cell division rate (GFAP+/BrdU+/EdU+) as well as 
recruitment of previously quiescent astrocytes into proliferation (GFAP+/EdU+), together with a 
decrease in the numbers of the astrocytes that proliferated only in response to the first lesion 
(GFAP+/BrdU+) (*P=0.0357) (D,E) Representative immunostainings from coronal sections within 
the lesion site depict the area used for cell quantifications. A second injury induced marked 
proliferation around the lesion site (EdU+ cells). Arrowheads indicate single positive BrdU+ cells 
(in red), single positive EdU+ cells (in green) and double positive BrdU+/EdU+ cells (in yellow). 
Yellow dashed line indicates the lesion site. (F) The vast majority of astrocytes (Aldh1L1+) around 
the lesion site were GFAP+. The few Aldh1L1+/GFAP- astrocytes are indicated by white, and 
Aldh1L1+/GFAP+ astrocytes by orange arrowheads. Data is depicted as median ± IQR. Scale bars 
represent 100 µm and 10 µm on inlays. SW: stab wound lesion, Ctx: cortex. 
Although the numbers of proliferating reactive astrocytes were similar on both 
injury conditions, the composition of their proliferative pool showed marked changes 
upon a second microlesion (Figure 5C-E). Following a single lesion, virtually all cycling 
astrocytes showed proliferative activity within 10d after injury (GFAP+/BrdU+ cells, 
Figure 5C), consistent with previous observations by live in vivo-imaging after SW injury 
in the cortical gray matter (Bardehle et al., 2013). However, a second lesion induced 
proliferation of previously quiescent astrocytes (GFAP+/EdU+), and induced a subset of 
astrocytes to reenter the cell cycle (GFAP+/BrdU+/EdU+) (Figure 5C). These results show 
for the first time that the proliferative capacity of astrocytes is not ultimately limited to a 
particular subset of parenchymal astrocytes, and that some astrocytes can proliferate 
more than once in response to subsequent pathological stimuli. 
GFAP is not expressed in immunohistochemically detectable levels by all 
astrocytes in the healthy CNS and as it is upregulated upon injury or inflammation, and 
therefore is used as a cell marker for astrocyte reactivity. Since we observed similar 
numbers of GFAP+ cells in both injury conditions, we evaluated if this could arise due to a 
change of GFAP expression in astrocytes or if the total numbers of astrocytic cells at the 
lesion site was indeed the same in these conditions. For that, we performed 
immunohistochemical analysis at the lesion site with Aldh1L1, a global astrocytic marker 
(Cahoy et al., 2008), and evaluated if GFAP labeling covered the whole astrocytic 
population in the penumbra. We observed that in the vicinity of the lesion in both injury 
paradigms there were only very few astrocytes identified with the global Aldh1L1 
astrocytic marker that did not express GFAP (Aldh1L1+/GFAP- cells, representing less 
than 2% of all Aldh1L1 cells) (Figure 5F). Therefore our analysis based on GFAP 
immunohistochemistry comprises the total astrocytic population in the lesion site. 
Our observations thus suggest the existence of mechanisms modulating the 
transition of reactive astrocytes into the proliferative state to ensure the maintenance of 
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astrocyte population homeostasis, similar to the homeostatic regulation that has been 
described for NG2-glia and microglia following ablation or injury (for review, see Jäkel 
and Dimou, 2017). 
3.1.3 Clonal analysis as a methodological approach to investigate 
astrocyte proliferation in vivo 
DNA incorporation of thymidine analogues is not a definite indicative of cell 
cycling activity and division, but of DNA synthesis, and thus can be an indicative of many 
other events in which DNA synthesis occurs, such as DNA repair, abortive cell cycle 
reentry and gene duplication (Taupin, 2007). In order to verify our observations of cell 
cycle activity from our thymidine analogue based approach, we used a second 
methodological tool, namely, the clonal analysis. This method consists on labeling cells in 
vivo and following the progeny of individual cells over time. As we were interested in 
astrocytes, we took advantage of GLAST-CreERT2-mediated recombination of cells in the 
multicolor R26-Confetti reporter mice (Bardehle et al., 2013; Calzolari et al., 2015). The 
GLAST-CreERT2 mouse functions based on the Cre-LoxP-system, which is a tool that 
allows cell and time-specific genomic DNA modifications.  
The Cre enzyme is a recombinase that targets, cuts, and recombines specific 
sequences of DNA, denominated LoxP sites. Placing these LoxP sites through genome 
editing in specific locations of the DNA allows genes to be activated, repressed or 
exchanged for other genes (Feil et al., 2009). In the GLAST-CreERT2 mouse (see Section 
2.2), the expression of Cre enzyme is driven by the GLAST gene promoter, which encodes 
a protein that is present in astrocytes, the glutamate aspartate transporter. Therefore, 
this enzyme will only be active in this specific GLAST- expressing cell type. Moreover, in 
these transgenic mice it is possible to control Cre activity and determine, for example the 
time point for it to be activated and perform the DNA modifications. This is achieved in 
this mouse line through the fusion of Cre to a modified estrogen receptor ligand binding 
domain, ERT2. Through this fusion, Cre remains in the cytoplasm of the cell and can only 
enter the nucleus upon ligand binding to estrogen receptor. Upon application of the 
ligand (in this case, tamoxifen), Cre can enter the nucleus and perform the DNA 
modifications in the cell through LoxP site recombination. Finally, we crossed this 
transgenic mouse line to a reporter line, namely, the R26-Confetti mice (see Section 2.2), 
which contain the editable DNA sites that Cre can recombinate. In this mouse line, Cre 
activity leads to expression of different fluorescent proteins in a stochastic manner. 
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Altogether, by using the double transgenic GLAST/Confetti mice, one can permanently 
label astrocytes with different fluorescent proteins through tamoxifen application. As this 
label is inheritable, it allows one to follow the cells and their progeny over time. 
In order to follow the progeny of an individual cell, that is to say, to be at the 
clonal level, it is necessary to achieve a sparse recombination. To define a recombination 
protocol that would allow us to address our experimental hypothesis, we first tested 5 
different tamoxifen concentrations for inductions consisting of a single i.p. injection (40, 
60, 80, 100 and 120 µg tamoxifen per gram of body weight). Mice underwent SW surgery 
1 week after tamoxifen treatment and received BrdU in drinking water following injury 
to label cells proliferating at the lesion site (Figure 6A). 
In the control animal that didn’t receive tamoxifen there were no recombined 
cells, whereas tamoxifen application induced a sparse labeling of astrocytes throughout 
the brain of treated animals in all the different tested concentrations (Figure 6B). As 
expected from previous observations, in the contralateral cortex there were no labeled 
astrocytes that had incorporated BrdU (data not shown) (for review see Sofroniew and 
Vinters, 2010). However, even at the highest recombination rate achieved we could 
barely identify recombined astrocytes in the penumbra that were also positive for BrdU 
(1 cell per brain analyzed, Figure 6C).  
Therefore, we increased the tamoxifen induction protocol by using a serial 
administration of 3 i.p. injections of 80 µg tamoxifen per gram of body weight, which is 
much below the level of induction that can lead to toxicity in mice (Lagace et al., 2007). 
With this new protocol we could detect recombined astrocytes that were also labeled 
with BrdU and therefore used it for the clonal analysis of proliferating astrocytes 
(Figures 7 and 8). 
As our ultimate goal was to analyze astrocyte proliferation, we based our clone 
definition on the incorporation of proliferation markers. Therefore, in our analysis, 
clones were defined as cells that were recombined (fluorescent positive cells: GFP+ or 
RFP+) and had incorporated proliferation markers (BrdU+ and/or EdU+). By basing our 
clonal analysis on the combination of two independent factors – presence of fluorescent 
protein and labeling with proliferation marker – we could increase the tamoxifen 
treatment to achieve a higher number of recombined cells while still remaining at a 
sparse distribution of proliferative cell clones. This enabled us to use this experimental 
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paradigm to effectively perform clonal analysis of proliferating astrocytes and their 
progeny after single and repetitive injuries (Figures 7 and 8). 
 
Figure 6. Establishing a tamoxifen induction protocol for clonal analysis of GLAST/Confetti 
mice. (A) The experimental paradigm used to test different induction concentrations of tamoxifen 
consisted on induction followed by a lesion and labeling of proliferating cells with BrdU in 
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drinking water. (B) Overview of brain sections of mice induced with different tamoxifen 
concentrations and of a control brain that was not induced with tamoxifen. White dashed box 
indicates area of inset represented in (c). (C) Lesion area with BrdU labeled cells of the animal that 
showed the highest recombination rate of cells, where we could find one BrdU+ recombined 
astrocyte (inlay). Yellow dashed line indicates the lesion site. Scale bars represent 100 µm and 10 
µm on inlay. TAM: tamoxifen, SW: stab wound lesion, Ctx: cortex. 
To perform clonal analysis of proliferating reactive astrocytes in our injury 
paradigm, we had to first establish a multicellular clone definition based on set 
parameters in our analysis. For this, it was essential to establish a threshold for the 
maximum distance between the single cells in a given clone. To achieve a meaningful and 
safe threshold value, we measured in all of the sections analyzed the minimum distance 
between two proliferating cells (BrdU+ and/or EdU+) with different fluorescent protein 
expression, which could, therefore, not have been originated from the same cell, and 
were named here as “false positive clones” (Figure 7 A,B). In other words, we measured 
the minimum distance between a proliferating GFP+ cell and a proliferating RFP+ cell. 
The minimum distance we could measure between “false positive clones” in all 
sections was of 20 µm (Figure 7B). In many sections we could not find false positive 
clones (Figure 7C), which indicates that the labeling we obtain with our recombination 
protocol is sparse enough to avoid the appearance of false positives that could be close 
enough to be interpreted as multicellular clones, but still enables us to analyze a 
meaningful number of clones. 
Although the minimum distance observed between “false positive clones” was of 
20 µm (Figure 7D), we took a conservative approach and determined the threshold for 
clone definition at a 5 µm maximum distance between two cell somata. Previous live in 
vivo imaging observations has shown that cortical gray matter astrocytes do not migrate 
following SW injury and that daughter cells do not drift apart following cell division 
(Bardehle et al., 2013). Thus, this threshold should be safe enough to both reliably and 
effectively detect multicellular astrocytic clones at the injury site. 
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Figure 7. Criteria used for multicellular clone definition: establishing a distance threshold 
between cells within a clone. (A) Measurement performed for determining the minimum 
distance between two proliferating cells with different fluorescent protein expression (“false 
positive clones”), and an example of what we defined as a multicellular clone. (B) The minimum 
distance we could measure between “false positive clones” in all sections analyzed was 20 µm, and 
we established the threshold of a 5 µm as the distance threshold for clone definition. Each dot on 
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the chart represents the minimum distance in each section analyzed. (C) Pie chart depicting the 
percentage of sections where it was not possible to measure the distance between “false positive 
clones” (in gray), as there were no two proliferating cells expressing different fluorescent proteins 
in the same section. (D) False positive clone with the shortest measured distance. Figures 1 to 5 
indicate the z-position in a 20 µm z-stack. Scale bars represent 10 µm. FP+: fluorescent protein 
expressing cell (GFP+ or RFP+). 
3.1.4 Repetitive injuries induced generation of larger astrocytic clones 
Recombination in GLAST/Confetti mice left an inheritable expression of 
fluorescent protein in astrocytic cells, which allowed us to follow the progeny of 
astrocytes that underwent cell division in response to single or repetitive lesions and 
incorporated proliferation markers (Figure 8A-C). Unfortunately, we did not succeed in 
achieving an immunostaining with the concomitant use of 4 markers (GFP, RFP, BrdU 
and EdU). Therefore, to analyze the total proliferative pool of astrocytes, we performed 
immunohistochemistry with an antibody that detects both BrdU and EdU with the same 
efficiency (anti-BrdU clone BU1/75) (Liboska et al., 2012). Thus the analysis is based on 
thymidine analogue-positive proliferating cells, without making a distinction between 
BrdU or EdU labeling. 
Interestingly, there was no difference in the number of recombined cells (GFP+ or 
RFP+) in the lesion site (ipsilateral cortex) and a corresponding area in the contralateral 
cortex (Figure 8D,F), indicating a reestablishment of astrocyte numbers following injury. 
Furthermore, there was no difference in the numbers of total and proliferating astrocytes 
between both injury conditions (Figure 8E,F). Altogether, these results confirm the 
population-based observations obtained in WT mice and suggest the existence of a 
mechanism for restoration of astrocyte population homeostasis following single and 
repetitive injuries. 
An unexpected, but yet interesting finding, was that on both groups a substantial 
amount of labeled astrocytes that incorporated proliferative markers (33-38%) 
constituted single cell clones (Figure 8G,H), indicating that many of the astrocytes that 
incorporate thymidine analogues do not generate long lasting progeny, which could be 
either due to a faulty or incomplete cell cycle or to the death of a daughter cell. 
However, most of the clones that incorporated proliferation markers did generate 
progeny, and after a single lesion we could find no clones with more than 2 cells (Figure 
8G,H), confirming previous live imaging data showing that astrocytes divide once and 
generate only 2 daughter cells after SW injury (Bardehle et al., 2013). After repetitive 
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injuries, however, we could observe the generation of clones consisting of 3 daughter 
cells (Figure 8G,H), indicating that a subset of reactive astrocytes can be activated by 
multiple pathological stimuli to undergo more than one round of cell division, consistent 
with our results obtained with BrdU and EdU sequential labeling in WT animals. 
 
Figure 8. Repetitive injuries induced an increase in astrocyte clone size. (A) Clonal analysis 
was performed in GLAST/Confetti mice, a double-transgenic mouse line resulting from the 
crossing between GLASTCreERT2 and R26R-Confetti lines. (B) The experimental paradigm used for 
this analysis consisted on the same injury and BrdU/EdU delivery conditions applied to WT 
animals, and only differed in the administration of tamoxifen prior to the first injury for 
recombination of astrocytes. (C) Induction with tamoxifen led to recombination and expression of 
different fluorescent proteins in astrocytes throughout the entire brain (D) The number of 
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recombined astrocytes (FP+) was similar in both intact (contralateral) and injured (ipsilateral) 
hemispheres, suggesting a repopulation of astrocytes to the same initial levels after single and 
repetitive injuries. (E) The number of non-proliferating and proliferating astrocytes in the lesion 
area (ipsilateral) was similar on both injury conditions. (F) Representative immunostainings 
depict recombined cells in the contralateral cortex and on the lesion site on both injury conditions 
(single and repetitive). Yellow dashed line indicates the lesion site. (G) Examples of clones 
analyzed and (H) quantifications of total recombined cells (upper pie charts) and clone size (lower 
pie charts) in each injury condition. Repetitive injuries induced an increase in astrocyte clone size, 
confirming our results obtained previously in WT animals with a population-based analysis. 
Yellow arrowheads indicate cell somata. Data is depicted as median ± IQR for dot plots and total 
percentage for pie charts. Scale bars represent 100 µm in (f) and 10 µm in (g). TAM: tamoxifen 
induction, SW: stab wound lesion, Ctx: cortex. 
3.1.5 Reactive astrocyte stem cell potential in vitro was not changed 
following repetitive injuries 
It has been demonstrated that different types of lesion trigger distinct levels of 
plasticity in reactive astrocytes, and that there is a positive correlation between astrocyte 
proliferation in vivo and stem cell potential in vitro (Sirko et al., 2013). As we observed 
that repetitive pathological stimuli could induce a change in the proliferative behavior of 
reactive astrocytes in vivo, we investigated whether this injury condition could also 
modulate the stem cell potential of reactive astrocytes in vitro through the neurosphere 
assay, in which one can characterize the capacity of a cell to self-renew and its 
multipotency (Figure 9A) (Reynolds and Weiss, 1992). 
Contrary to what we expected, reactive astrocytes derived from the penumbra 
after repetitive pathological events showed no difference in plasticity in vitro when 
compared to those obtained from single lesioned tissue. Based on quantitative and 
qualitative analysis there were no changes in their potential to generate neurospheres 
(Figure 9B), as well as their ability to self-renew (Figure 9C) or in their differentiation 
potential (Figure 9D,E). This data indicates that a second lesion did not elicit a change in 
astrocyte stem cell potential; however this result could also be due to changes within the 
repetitive injured parenchyma at intrinsic and/or extracellular levels in the multiply 
injured parenchyma that could affect astrocyte plasticity. 
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Figure 9. Repetitive injuries did not induce a change in astrocyte stem cell potential in vitro. 
(A) The neurosphere assay is the gold standard method for analysis of stem cell potential, in 
which two hallmarks of stem cells – self-renewal and differentiation – are investigated. (B,C) The 
number of neurospheres formed in the first (B) and on subsequent passages (C) was increased in 
the lesioned versus intact cortex, but there was no difference between the two injury paradigms 
(n=2 animals in intact, and 6 in single and repetitive lesions group). *P= 0.0246 in Kruskal-Wallis 
Test and P<0.05 in Dunn’s Multiple Comparison post hoc test. (D) Differentiation assay analysis 
showed no difference in the differentiation potential of neurospheres obtained from both injury 
paradigms. (E) Examples of neurospheres analyzed, in which the presence of 3 different neural 
cell types (astrocytic: GFAP, oligodendrocytic: O4, and neuronal: βIII-tubulin) was analyzed in 
each neurosphere to determine its differentiation potential (gliogenic or neurogenic). Data is 
depicted as median ± IQR in (c) and percentage and total number of neurospheres analyzed in (d). 
Scale bars represent 100 µm. 
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3.1.6 Repetitive injuries induced changes in the lesion environment, 
evidenced by an exacerbated proliferation of 
microglia/macrophages 
It is known that other types of glial cells, such as NG2-glia and microglia show a 
pronounced proliferative response to different types of brain injury (Dimou and Götz, 
2014; Simon et al., 2011). Following repetitive pathological stimuli, we observed a 
marked increase in the proliferative activity of non-astrocytic GFAP- cells, so we set out to 
determine the proliferative response of NG2-glia and microglia upon repetitive 
pathological events. Immunohistochemical analysis revealed that NG2-glia (NG2+) and 
microglia/macrophages (Iba1+) also proliferate after repetitive lesions (Figure 10A). 
Interestingly, similar to astroglial cells, NG2+ cells also showed a comparable number of 
proliferating cells following single and repetitive injuries and maintained homeostatic 
cell numbers across the different injury paradigms (Figure 10B,C). However, 
microglia/macrophages (Iba1+ cells) react to the secondary injury with an increased 
proliferation, resulting in an also increased population size in the penumbra after 
repetitive lesions (Figure 10B,C), which is a known phenomenon termed microglia 
priming (Witcher et al., 2015). 
Cycling cells quantified with the use of 3 distinct markers (GFAP, NG2 and Iba1) 
amounted to almost 100% of the total proliferative cells, and although it is known that 
also other cell types in the brain proliferate in response to invasive injury (e.g. 
endothelial cells, our analysis suggests they do not represent a substantial amount of 
cells within the total proliferative population. 
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Figure 10. Macro- and microglial cells show different proliferative response to repetitive 
injuries. (A) Representative immunostainings depict the area used for quantifications of different 
glial cells on the injury site based on the markers Iba1 (microglia/macrophages), NG2 (NG2-glia) 
and GFAP (astrocytes). Examples of proliferating cells (BrdU+ and/or EdU+) are depicted in inlays. 
Yellow dashed line indicates the lesion site. (B) While the number of proliferating macroglia 
(GFAP+ and NG2+) was not changed in repetitive injuries compared to a single injury, 
microglia/macrophages (Iba1+) showed an exacerbated proliferative response after a second 
lesion (P=0.0357). (C) The total number of macroglial cells (GFAP+ and NG2+) remained the same 
after single or repetitive injuries; however, microglia/macrophages (Iba1+) showed an increase in 
the total population number following repetitive injuries (P=0.0357). (D) Quantifications of 
GFAP+, NG2+ and Iba1+ proliferating cells amounted to nearly 100% of all proliferating cells in the 
injury site. Data is depicted as median ± IQR for dot plots and mean ± SD for graph with 
percentage data in (d). Scale bars represent 100 µm and 10 µm on inlays. Ctx: cortex. 
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3.1.7 Absence of infiltrating monocytes induced a change in the mode 
of recruitment of astrocytes into proliferation following repetitive 
lesions 
The observation that the microglia/macrophage Iba1+ cell population was largely 
increased upon a second lesion, while macroglia cell population numbers remained 
unchanged, led us to question whether the inflammatory environment could have an 
effect on modulating the proliferation of astrocytes. 
As one of the outcomes of traumatic brain injury is the upregulation of 
chemokines (e.g. CCL2) by astrocytes and microglia, leading to the recruitment of 
monocytes into the brain parenchyma (Gyoneva and Ransohoff, 2015), we questioned 
whether an impairment of monocyte infiltration could have an influence in astrocyte 
proliferative behavior upon repetitive lesions, for example on the regulation of the 
relative contribution of self-renewing astrocytes versus new recruitment of astrocytes 
into proliferation. 
In order to address this question, we performed the same lesion and labeling 
paradigm in CCR2-/- mice (Saederup et al., 2010), in which monocyte infiltration from the 
blood vessels into the brain parenchyma after injury is impaired and has been shown to 
strongly increase astrocyte proliferation (Frik et al., 2018). 
Quantitative analysis of cycling activity of cells within the penumbra indicated 
significant changes in the lesion environment in CCR2-/- mice compared to WT mice after 
single and repetitive lesions, with a visible increase of BrdU-labeled cells in the absence 
of monocyte infiltration in both conditions (Figure 11A). 
In CCR2-/- mice there was a significant increase of non-astrocytic proliferating 
cells (GFAP-) compared to WT mice following a single lesion, but this difference was not 
observed between both genotypes after repetitive injuries (Figure 11 B). Further analysis 
of the different subsets of non-astrocytic cycling cells according to their temporal profile 
of proliferation showed that, after a single lesion, only the population of GFAP-/BrdU+ 
cells was changed, showing an increased number in CCR2-/- compared to WT mice (Figure 
11C). However, following repetitive lesions, there was an increased number of all subsets 
of proliferating cells, with an increase in both BrdU-labeled populations (GFAP-/BrdU+ 
and GFAP-/BrdU+/EdU+) and a decrease in the GFAP-/EdU+ population in CCR2-/- 
compared to WT mice (Figure 11D). 
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Figure 11. Proliferation of cells in the lesion area is modulated by monocyte infiltration. (A) 
Representative immunostainings show marked changes in the lesion environment depending on 
the presence (WT) or absence (CCR2-/-) of infiltrating monocytes, with increased number of BrdU+ 
cells in CCR2-/- mice compared to WT mice after single and repetitive injuries. Yellow dashed line 
indicates the lesion site. (B) The number of non-astrocytic (GFAP-) proliferating cells was 
increased in CCR2-/- mice after single and repetitive injuries compared to single injured WT 
animals (*P=0.0159). (C) In the absence of infiltrating macrophages (CCR2-/-) following a single 
lesion there was an increase of non-astrocytic BrdU+ cells compared to WT animals (*P=0.0159). 
(D) Upon repetitive lesions, there was an increase of non-astrocytic BrdU+ and BrdU+/EdU+ cells 
and decrease of EdU+ cells in the absence of invading monocytes (CCR2-/-) (*P=0.0357). Data is 
depicted as median ± IQR. Scale bars represent 100 µm and 10 µm on inlays. Ctx: cortex. 
Our experimental paradigm using double labeling with BrdU and EdU is, 
unfortunately, not optimal for the characterization of subsets of highly proliferative cells, 
since the thymidine analogue that is delivered first (BrdU) can get diluted out of the cell’s 
DNA in case of multiple cell divisions. As a matter of fact, this BrdU dilution can be 
observed both visually in immunostainings of WT animals after repetitive lesions 
compared to single lesion (Figure 11A), and in the quantifications of GFAP- proliferating 
cells, in which there is a substantial decrease in the number of GFAP-/BrdU+ cells and 
concomitant increase of GFAP-/EdU+ cells after a second lesion in WT animals. This could 
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arise from either the death of GFAP-/BrdU+ cells upon a second injury, or due to a high 
proliferative response of these cells to the second lesion, the latter being suggested in our 
results by the huge increase in the number of GFAP-/EdU+ cells that we observe upon a 
second injury in WT mice. 
Therefore, although this thymidine labeling paradigm is not optimal to analyze 
highly proliferative cells, one can speculate about the overall higher number of GFAP-
/BrdU+ cells and lower number of GFAP-/EdU+ cells in CCR2-/- mice. One hypothetical 
explanation for this could be that, in these mice, microglia (which are the main GFAP- 
proliferative population in WT mice) achieve a state of exhaustion after exacerbated 
proliferation following a single lesion and don’t show a further increased proliferation 
following a second insult (Figure 11B). It would, therefore, be interesting to further 
analyze the microglia response capacity or microglia priming in the context of multiple 
injuries in CCR2-/- mice, in order to evaluate the importance of monocyte infiltration in 
the modulation of local microglia proliferation. 
Altogether, our results show that the proliferative cellular milieu of non-
astrocytic cells is drastically changed at the lesion site of mice in which monocyte 
invasion is impaired both after single and repetitive injuries. 
Analysis of the effects of the absence of monocyte infiltration on astrocyte 
proliferation surprisingly showed that, also in CCR2-/- mice, astrocyte numbers were 
perfectly maintained after single and repetitive injuries (Figure 12A-C). However, the 
proliferative repertoire of astrocytes was changed in CCR2-/- mice compared to WT after 
repetitive lesions (Figure 12D). After a single SW injury, we observed no increase of 
astrocyte proliferation over the first 24 days after injury in CCR2-/- mice (Figure 12E). 
Upon repetitive injuries, however, the absence of invading monocytes enhanced cell-
cycle reentry of reactive astrocytes, resulting in a 2-fold increase in the proportion of 
GFAP+/BrdU+/EdU+ cells within the penumbra of CCR2-/- mice compared to WT animals 
(Figure 12F). This switch to self-renewing proliferation was accompanied by significantly 
reduced recruitment of quiescent astrocytes into the cell cycle, with much reduced EdU+ 
astrocytes after repetitive injury in CCR2-/- mice (Figure 12F). Thus, our analysis strongly 
suggests that invading monocytes play a key role in recruiting previously quiescent 
astrocytes into proliferation. 
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Altogether, these observations imply that signals coming from invading 
monocytes in the lesioned environment regulate the proliferative behavior of reactive 
astrocytes, especially upon multiple injuries. 
 
Figure 12. Astrocyte proliferative behavior is modulated by the infiltration of monocytes in 
the lesion area. (A) Representative immunostainings show GFAP expression in different genetic 
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backgrounds and injury conditions. Inlays represented in the lower panels contain examples of 
the different subsets of proliferative astrocytes: GFAP+/BrdU+ (red arrowheads), 
GFAP+/BrdU+/EdU+ (yellow arrowheads) and GFAP+/EdU+ (green arrowheads). Yellow dashed 
line indicates the lesion site. While the numbers of total (B) and proliferating (C) astrocytes were 
comparable across genotypes and injury paradigm, the proliferative repertoire (D) of astrocytes 
was modulated by the presence (WT) or absence (CCR2-/-) of monocyte infiltration following 
repetitive lesions. (E) Quantitative analysis of the proliferative populations of astrocytes yielded 
similar results in both genetic backgrounds following a single lesion. (F) Upon repetitive injuries, 
the absence of infiltrating macrophages (CCR2-/-) resulted in an increase in the number of self-
renewing astrocytes (GFAP+/BrdU+/EdU+) and decrease of newly recruited astrocytes into 
proliferation (GFAP+/EdU+) (*P=0.0357). Data is depicted as median ± IQR for dot plots and mean 
± SD for pie charts. Scale bars represent 100 µm and 10 µm on inlays. Ctx: cortex. 
3.1.8 Age-related changes in reactive astrocyte transcriptional 
regulation 
As demonstrated in the previous section of this thesis, reactive astrocytes show 
different responses to injury depending on environmental cues. The effect of the lesion 
environment on modulating reactive astrocyte properties has been previously described 
in many different pathological contexts (Anderson et al., 2014; Ferrer, 2017; Frik et al., 
2018; Liddelow et al., 2017; Sirko et al., 2013). 
Although much progress has been done to understand astrocytic responses in 
different pathological environments, until recently, little was known about the properties 
of reactive astrocytes in the injured aged brain.  
Natural aging is associated with a plethora of changes in microglia and immune 
system function (von Bernhardi et al., 2015; Hefendehl et al., 2014), and recovery 
outcomes from damage are worse in the aged compared to young brains (Fonarow et al., 
2010; Zhang et al., 2005). Therefore, our work group addressed the question of whether 
astrocyte response to lesion was changed in the aged brain where there seem to be 
different environmental cues. We found that astrocytes in the post-traumatic aged cortex 
have an impaired proliferation, and this leads to a reduction of their population cell 
numbers in the penumbra (Heimann et al., 2017). Interestingly, these proliferation 
deficits seem to be intrinsic, as astrocytes become refractory to signaling factors that 
promote proliferation, such as SHH (Heimann et al., 2017; Sirko et al., 2013). 
In order to get more insight on possible mechanisms for this impaired 
proliferative response, we performed transcriptional analysis of genes known for 
regulation of proliferation or astrocyte reactivity. For this purpose, I isolated reactive 
astrocytes from the post-traumatic cortical parenchyma of Aldh1L1-eGFP mice through 
FACS-sorting and processed the material for qPCR analysis (Figure 13A,B). 
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Gene expression analysis showed a trend towards downregulation of mRNA 
levels of SHH transducer Smoothened (Smo), SHH receptor Patched (Ptch1) and their 
effector cyclin D1 (Ccnd1) in GFP+ astrocytes from the aged brain (Figure 13C). These 
transcriptional changes in different players of the SHH pathway imply an interference 
with this pathway in astrocytes from the aged brain, which could explain why they are 
refractory to SHH signaling and suggest an intrinsic proliferation deficit of these cells. 
Interestingly, mRNA levels of GFAP showed a trend towards downregulation in 
astrocytes isolated from aged animals (Figure 13C), which could have implications in the 
overall poor outcome of tissue restoration and recovery from lesion. 
 
Figure 13. Gene expression analysis of astrocytes from the post-traumatic young and aged 
cerebral cortex. (A) Experimental paradigm used for isolation of reactive astrocytes via FACS-
sorting and steps involved in material processing for gene expression analysis with RT-qPCR. (B) 
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FACS plots show the final sorting gate used for isolation of GFP+ astrocytes, based on cell size 
(forward scatter area, FSC-A) and GFP expression. A WT sample processed in parallel was used to 
set the gate for GFP fluorescence (shown in the left). GFP+ cells (upper part of graph) were 
positively sorted from cell suspensions of young and aged injured brains. (C) Bar graphs depict 
levels of mRNA from different genes determined by qRT-PCR (data is plotted as mean ± SEM of 
technical triplicates, n=3 animals/group, pooled in 1 sample per group). 
3.2 Environment-dependent plasticity of cerebral cortex 
reactive astrocytes 
3.2.1 Transplantation as a tool to evaluate differentiation potential of 
cortical reactive astrocytes and aNSCs in vivo 
In order to assess whether cortical reactive astrocytes can give rise to different 
cell types in vivo when relocated to a more plastic environment, and to evaluate to which 
extent the local environment can influence their differentiation potential, we isolated and 
transplanted these cells into neurogenic environments and characterized them after a 
few weeks to assess their cell fate. 
For this purpose, we isolated tissue from the injured cortical gray matter of actin-
GFP mice at 5 days after cortical SW injury and also from the SEZ, which contains a bona 
fide NSC population, which we used for comparison in our analysis. We cultured both 
populations of cells for 2 weeks in vitro through the neurosphere culture for expansion 
and transplanted these as single cell suspensions into the hippocampal DG in the adult 
mouse brain, and into the lateral ventricles of the developing brain of E13 embryos of WT 
animals, in which there is a high level of ongoing neurogenesis (Figure 14A). As an 
additional control to validate our transplantation experiments, we transplanted the SEZ-
derived cells homotypically into the SEZ of WT animals. We analyzed the fate of 
transplanted cells at 2 and 4 weeks post transplantation (wpt) in all different host 
environments through immunohistochemistry using well-established cell markers for 
different types of cells: GFAP (astroglia), Olig2 (oligodendroglia), DCX (immature 
neurons) and NeuN (mature neurons) (Figure 14A). 
SEZ-derived cells transplanted homotypically into the SEZ could migrate from the 
transplantation site through the rostral migratory stream (RMS) into the olfactory bulb 
(OB) at 2 and 4 wpt (Figure 14B). As there were no differences in the distribution and 
differentiation of the transplanted cells analyzed at both time points, only the data from 4 
wpt is shown here (Figure 14C,D). 
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Figure 14. Transplantation of actin-GFP neurosphere-derived cells from the injured 
cortical gray matter and SEZ into neurogenesis-permissive environments. (A) Experimental 
paradigm used to assess the differentiation potential of cortical reactive astrocytes compared to 
bona fide aNSCs in different neurogenic environments. (B) As a positive control to validate our 
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transplantation experimental procedure, we performed homotypic transplantations of SEZ-
derived aNSCs into the SEZ. (C) At 4 weeks post transplantation, the majority of transplanted cells 
could still be found within the transplantation site (SEZ), few cells were located within the RMS 
with a migratory morphology and many cells could be found within the OB and showed a distinct 
mature neuronal morphology. (D) Examples of distinct cell types that SEZ-derived cells could 
differentiate into within the SEZ (few DCX+, Olig2+ and NeuN+), RMS (mainly DCX+) and in the OB 
(mostly NeuN+, with few DCX+ cells). Yellow arrowheads indicate double-positive cells. Scale bars 
represent 100 µm in (c) and 10 µm in (d). SW: stab wound lesion, SEZ: subependymal zone of the 
lateral ventricle, DG: dentate gyrus of the hippocampus, dpi: days post injury, OB: olfactory bulb, 
RMS: rostral migratory stream, wpt: weeks post transplantation.  
The majority of cells could be found in the transplantation site and remained in 
the astrocytic lineage (GFAP+), but there were also a few GFP+ transplanted cells in the 
SEZ that differentiated into other cell types, evidenced by their expression of DCX, Olig2 
and NeuN markers (Figure 14D). The few transplanted cells found within the RMS were 
mostly DCX+ and had a distinct migratory morphology. On the other hand, the vast 
majority of the cells present in the OB were NeuN+ with a mature neuronal morphology, 
with a few DCX+ cells exhibiting also a neuronal morphology (Figure 14D). 
These results indicate that our methodological approach as a whole – from the 
isolation, neurosphere culture and transplantation of cells – is suitable for analyzing cell 
differentiation potential in vivo, since we were able to confirm the expected phenotype of 
SEZ cells when we transplanted these homotypically into their region of origin in host 
WT animals. 
3.2.2 Differentiation potential of SEZ aNSCs and cortical reactive 
astrocytes in the adult hippocampal DG 
Analysis of differentiation potential after at 2 and 4 weeks of heterotypical 
transplantation of cells into the adult DG indicated a higher plasticity of SEZ-derived cells 
compared to cells derived from the injured cortex, as they gave rise to cells of three 
different lineages - astrocytic (GFAP+), oligodendrocytic (Olig2+) and immature neurons 
(DCX+) (Figure 15). Cells derived from the SEZ remained mostly in the astrocytic lineage 
(GFAP+) at both time points analyzed, but also gave rise to a substantial amount of 
oligodendrocytic cells (Olig2+) and immature neurons (DCX+). Surprisingly, despite the 
presence of many immature neurons in both time points analyzed, SEZ-derived cells 
largely did not differentiate into mature neurons (NeuN+), even at 4 wpt (Figure 15A,B).  
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Figure 15. Transplantation of actin-GFP neurosphere-derived cells from the SEZ and 
injured cortical gray matter into the adult DG. (A) Summary table of results obtained from 
differentiation analysis of transplanted cells from both sources into the DG. SEZ-derived cells 
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showed a greater differentiation potential than cortical reactive astrocytes (higher proportion of 
Olig2+ and DCX+ cells), but still failed to give rise to mature neurons (NeuN+) in this environment. 
Reactive astrocytes derived from the injured cortex remained in the glial lineage and largely did 
not give rise to neurons (immature or DCX+ and mature or NeuN+). Data represented in total cell 
numbers analyzed and relative proportions for each combined immunostaining (n=1-2 animals 
per condition). (B) Examples of transplants from both sources at different analysis time points in 
overview (upper row), and of different cell fates identified based on well-defined cell markers. 
White arrowheads indicate double-positive cells, and gray arrowheads indicate GFP+ transplanted 
cells that are negative for the cell marker analyzed. Scale bars represent 100 µm on upper row and 
10 µm on the subsequent rows. SEZ: subependymal zone, DG: dentate gyrus, wpt: weeks post 
transplantation. 
Since we have shown that upon homotypic transplantation SEZ cells could 
migrate into the OB and differentiate into mature neurons within 2 weeks, these results 
indicate that the DG environment, although being neurogenic, may lack key signals to 
support the maturation of SEZ-derived neuroblasts. 
Cells derived from the injured cortex remained in the glial lineage after 2 and 4 
wpt, with the vast majority of the cells keeping their astrocytic fate (GFAP+) and very few 
differentiating into oligodendrocytic cells (Olig2+). We could find virtually no immature 
neurons within the transplants from injured cortex derived cells, which also raises 
concerns for interpreting the few mature neurons (NeuN+) that we could find in these 
transplants, as well as the ones derived from SEZ cells, since they are very low in number 
(Figure 15A,B). Therefore, we can conclude that both cell sources largely failed to give 
rise to mature neurons (NeuN+) in this adult neurogenic niche. 
Since even the cells derived from the SEZ, which is a neurogenic niche containing 
bona fide aNSCs, failed to generate mature neurons in the adult DG, we decided to 
analyze the differentiation potential of both cell types in yet another highly pro-
neurogenic environment with a more robust generation of neurons: the developing brain 
of the E13 embryo. 
3.2.3 Differentiation potential of aNSCs and cortical reactive astrocytes 
in the embryonic brain 
In order to further assess the differentiation potential of cortical reactive 
astrocytes and SEZ aNSCs in vivo, we transplanted these cells in a different neurogenesis 
supportive environment, namely the E13 developing brain. 
As we performed intraventricular transplantations, we characterized the 
distribution of transplanted cells obtained from the different sources throughout the 
brains at the time points of our analysis (Figure 16A,B).  
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Figure 16. Homing of adult SEZ and injured cortex derived cells in the developing brain. (A) 
Frequency of integration of transplanted cells in the different brain regions over both time points 
analyzed. Data represented in percentages (number of brains in which transplanted cells were 
detected in a given region over all brains containing transplanted cells). (B) Heat map displays 
number of transplanted cells quantified in each brain region in a serial analysis of brain sections. 
Each column contains data from a single brain. Cell source, time point of analysis and the 
experiment number are indicated on the top rows. Data was collected in two independent 
experiments, n=2-4 embryos per condition. Wpt: weeks post transplantation, OB: olfactory bulb, 
SEZ: subependymal zone, LV: lateral ventricle. 
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We were able to find transplanted cells derived from both SEZ and injured cortex 
in different regions throughout the neuraxis, with a widespread antero-posterior and 
dorso-ventral distribution. Furthermore, we observed a preferential distribution of 
transplanted cells in certain brain regions (corpus callosum, thalamus, hypothalamus) 
that was similar on cells originated from both sources (Figure 16A,B). 
However, some differences in distribution on the transplanted cells depending on 
the cell source were evident in our analysis. We found transplanted cells derived from 
the SEZ in regions related to the endogenous migration pathway of these cells (SEZ, RMS 
and OB) with a higher frequency than cells derived from the injured cortex. As a matter 
of fact, we did not find transplanted cells in the OB in any of the brains transplanted with 
cortically derived cells. On the other hand, it was interesting to note that cells derived 
from the SEZ displayed homing at the isocortex at a much higher frequency than 
cortically derived cells (Figure 16A,B). 
Cells derived from SEZ neurospheres that were transplanted into the E13 brain 
gave rise to neurons (NeuN) both at 2 and 4 wpt. Interestingly, the generation of neurons 
in the OB (which is expected from these cells) could be observed in half of the 
transplanted embryos at 2 and 4 wpt, whereas the generation of neurons in ectopic 
regions (hypothalamus and midbrain) was only observed at 2 wpt (Figure 17A,B). It is 
interesting to note that in all of the brains transplanted with SEZ-derived cells in which 
there were transplanted cells in the OB, we were able to find neurons among these cells. 
However, even though we found transplanted cells in the hypothalamus and midbrain of 
almost all of the transplanted embryos, neurons within these regions were found in few 
brains. This suggests that SEZ-derived cells are highly responsive to local environmental 
cues present in the OB for neuronal differentiation, whereas the cues present in other 
brain regions, such as the hypothalamus and midbrain, although eliciting neuronal 
differentiation in some cases, do not show the same success in this process as the ones 
present in the OB, which is the endogenous terminal differentiation region of these cells. 
Outside of the aforementioned regions, the SEZ-derived cells gave rise to cells 
that did not have neuronal morphology or express the neuronal markers that we used in 
our analysis (NeuN and DCX) and mainly displayed the morphology and expression 
markers of glial cells (GFAP+ and Olig2+) (Figure 17A,B). 
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Figure 17. Differentiation of adult SEZ- and injured cortex-derived cells in the developing 
embryonic brain. (A) Summary of results of differentiation potential analysis of both cell sources 
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upon transplantation in the E13 embryonic brain at 2 and 4 wpt. Cells derived from the SEZ gave 
rise to neurons (NeuN) in the OB of 50% of the transplanted brains at both time points. Neuronal 
differentiation in SEZ non-related regions (hypothalamus and midbrain) was observed only at 2 
wpt. All of the transplanted cells found in the regions indicated in green did not express neuronal 
markers and were largely glial (GFAP or Olig2). Transplanted cells derived from the injured cortex 
did not give rise to neurons in the developing brain in any brain region at 2 or 4 wpt. Data was 
collected in 2 independent experiments, n=2-4 embryos per condition. (B) Examples of different 
cell phenotypes derived from transplanted cells and their integration site in different brain 
regions at 2 and 4 wpt. Wpt: weeks post transplantation, SEZ: subependymal zone, LV: lateral 
ventricle, ctx: cortex. 
In all of the brains that were transplanted with cells derived from injured cortex 
neurospheres, we weren’t able to find any cells that had either a neuronal morphology or 
expressed neuronal cell markers. We could identify many glial cells in different regions of 
the brain expressing astrocytic (GFAP) or oligodendrocytic (Olig2) cell markers (Figure 
17A,B). 
In summary, analysis of SEZ and injured cortex-derived cells transplanted into 
the embryonic brain indicates once more that cortical reactive astrocytes largely do not 
give rise to neuronal cells in vivo, despite showing a widespread migration along the 
neuraxis and being found in many different brain regions. Bona fide aNSCs derived from 
the SEZ, on the other hand, can differentiate into neuronal cells in the developing brain 
and preferentially do so in their intrinsic neurogenic niche, generating mature neurons 
mainly in the OB. 
Altogether our results from transplantations in neurogenesis-supportive 
environments in both the adult and embryonic brain show that, despite having the 
potential to generate neurons in vitro, reactive astrocytes are largely incapable of giving 
rise to neurons in vivo. 
3.3 Origin of neurosphere-forming cells in the injured cerebral 
cortex gray matter 
3.3.1 Analysis of origin of neurosphere-forming cells in Emx1-GFP mice 
In order to investigate whether the neurosphere forming cells present in the 
injured cortical tissue are locally derived from resident parenchymal astrocytes that 
acquire plasticity following lesion, or if they consist of SEZ cells that migrate into the 
cortical lesion site, we used transgenic mouse line tools to label and follow cells 
according to their region of origin. 
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More specifically, we used double transgenic Emx1-GFP mice obtained from 
crossings between the Emx1Cre (Iwasato et al., 2000) and CAG-CAT-eGFP reporter lines 
(Nakamura et al., 2006). Emx1 is a gene expressed exclusively in the dorsal 
telencephalon from embryonic stages of development to adulthood, and the Emx1Cre 
transgenic line shows a pattern of Cre expression specific to this brain region (Iwasato et 
al., 2000). Therefore, in our double transgenic Emx1-GFP mouse line we expected to 
obtain permanent GFP labeling in cells located in the cortex and hippocampus, but not in 
the SEZ. 
Immunohistochemical analysis of intact brains largely confirmed the expression 
pattern we expected to find, with a broad labeling of cells in the dorsal telencephalon, but 
not in other brain regions (Figure 18A). We identified many GFP-labeled cells in the 
cortex that were also expressing astrocytic markers (GFAP/S100β), and these were 
distributed through all cortical layers (Figure 18B). The SEZ was mainly devoid of GFP-
labeled cells, but we could find one GFP+ cell at the ventricular zone that was also 
GFAP/S100β+ upon analysis of serial sections of two intact mouse brains. There were 
many GFP+ astrocytic cells in the neighboring striatal area (Figure 18B). 
Altogether, through immunohistochemical analysis of intact Emx1-GFP brains we 
were able to detect robust GFP labeling of cortical cells, while only very few GFP-labeled 
cells were found in the SEZ, confirming that this double transgenic mouse line could be 
used to investigate if the neurospheres derived from injured cortical tissue were 
originated from resident cortical cells. 
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Figure 18. Emx-GFP brain sections show expression of GFP reporter largely localized to the 
dorsal telencephalon. (A) Overview of serial coronal sections presented in an anterior to 
posterior sequence shows a broad GFP labeling of cells in the dorsal telencephalic areas (isocortex 
and hippocampus), while ventral telencephalic areas and midbrain are mainly devoid of GFP 
expression. (B) Immunohistochemical analysis showed a broad labeling of GFP cells in the cortex 
(upper row), with many GFP-labeled cells also expressing astrocytic markers (GFAP/S100β). The 
SEZ (lower row) was mainly devoid of GFP-labeled cells, but we could find a GFP+ cell at the 
ventricular zone that was also GFAP/S100β+. Many GFP-labeled astrocytic cells were found in the 
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adjacent striatal area. Arrowheads indicate double positive cells (GFP+ and GFAP/S100β+). Scale 
bars represent 100 µm.  
We performed the neurosphere assay with SEZ and cortical tissue that we 
extracted from intact or stab wound-lesioned mouse brains at 5 dpi (n=3 animals per 
condition). Cells were cultured for 14 div and at this time point we quantified the number 
of neurospheres as well as their GFP expression for each condition (Figure 19A). 
Neurospheres obtained from SEZ tissue in all conditions were largely GFP- 
(Figure 19B) but we could find few neurospheres that were either GFP+ or were a mix of 
GFP+ and GFP- cells, which were termed GFP+/- mosaic neurospheres. On the other hand, 
in the neurospheres obtained from cortical tissue there was overall a higher proportion 
of GFP+ neurospheres, albeit at a very lower number compared to the total amount of 
neurospheres we obtained from the SEZ (Figure 19C). 
This substantial difference in the proportion of GFP+ neurospheres that we found 
between SEZ tissue (1.3-2.6%) and cortical tissue (30-50%) strongly suggests that the 
neurosphere-forming cells present in the injured cortical tissue are indeed originated 
from resident parenchymal astrocytes, and not from SEZ-derived cells that migrate into 
the cortical lesion site. However, due to the presence of few GFP+ cells in the SEZ detected 
via immunohistochemistry in intact brains of Emx1-GFP mice, as well as the few GFP+ 
neurospheres we could identify in the different SEZ-derived cultures, we cannot formally 
exclude that these few GFP+ cells present in the SEZ under physiological conditions could 
migrate to the cortex following an injury and thus contribute to neurosphere formation. 
We proceeded by developing another experimental paradigm, where our goal 
was to achieve a more specific labeling of cortical cells, with no labeling of cells in the SEZ 
region. For this purpose, we tested a labeling approach with an AAV vector injection in 
the intact somatosensory cortex (Figure 20). 
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Figure 19. Neurospheres from intact and injured brains of Emx1-GFP mice show evidence 
for local origin of neurosphere-forming cells in the cortex. (A) Experimental paradigm used to 
investigate the origin of neurosphere-forming cells present in the injured cortical tissue. We 
extracted both intact or SW injured brains at 5 dpi from Emx1-GFP mice and performed the 
neurosphere assay with tissue obtained from the SEZ or cortex. The cells were cultured for 14 div, 
after which the neurospheres were quantified and characterized according to the presence or 
absence of GFP expression. (B) Almost all of the neurospheres generated from SEZ tissue in all 
different conditions were GFP-. Examples of neurospheres quantified from SEZ cultures are shown 
in the pictures to the left, and the total numbers of neurospheres quantified per condition, as well 
as their GFP expression pattern, are indicated on the bar graphs to the right. (C) Between 30-50% 
of the neurospheres generated from cortical tissue in all of the conditions were GFP+. Examples of 
neurospheres quantified from cortical tissue cultures are shown in the pictures to the left, and the 
total numbers of neurospheres and their GFP expression are indicated on the bar graphs to the 
right. Data is represented in absolute numbers, n=3 animals per condition. Scale bars represent 
200 µm.  
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3.3.2 Labeling of cerebral cortex astrocytes with an AAV reporter 
vector 
In order to achieve an experimental paradigm where we can rule out the 
existence of any fluorescent protein labeled cells in the SEZ, we investigated if we could 
achieve cortex-specific labeling via injection of viral vectors in the cortex. 
For this purpose, we injected AAV-TdTomato viral vectors with reporter 
expression driven by a GFAP promoter (see Section 2.5.4) (Shigetomi et al., 2013) into the 
intact somatosensory cortex gray matter of WT mice. Through this approach, we 
expected to achieve a region- and cell-specific labeling of cortical astrocytes. 
Immunohistochemical analysis showed a widespread labeling of cortical 
astrocytes around the injection site, but labeling was specific to this region and no 
labeled cells were detected in the SEZ and surrounding areas (Figure 20A,B). This 
indicates that our approach is optimal to achieve specific labeling of cortical cells (or in 
this case, of cortical astrocytes), and can be employed to further investigate the origin of 
neurosphere-forming cells present in injured cortical tissue. As AAV vectors don’t 
integrate into the genome, this labeling approach with the AAV-TdTomato reporter 
would not be an optimal tool to evaluate reporter expression in the neurospheres, as 
highly proliferative cells would dilute the viral DNA and loose reporter expression. 
In order to circumvent this problem, we carried on to set up a new experimental 
paradigm using injections of AAV-iCre (see Section 2.5.4) (Druckmann et al., 2014) in 
floxed GFP-Reporter mice (Nakamura et al., 2006) to achieve a permanent labeling of 
cortical astrocytes. 
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Figure 20. Specific labeling of cortical astrocytes through AAV-tdTomato virus injection in 
the intact cortex. (A) Immunohistochemistry of serial coronal brain sections shows the viral 
spread through the antero-posterior axis, with reporter expression localized mainly to the 
somatosensory cortex. SEZ and surrounding regions were completely devoid of TdTomato 
reporter labeling (n=3 animals). (B) Immunohistochemistry of injection site depicts reporter 
expression pattern, with many labeled astrocytes (RFP+ and GFAP/S100β+). Scale bars represent 
100 µm. 
3.3.3 Analysis of origin of neurosphere-forming cells in GFP-Reporter 
mice injected with AAV-iCre viral vector to label cortical cells 
In order to assess whether cortical astrocytes could acquire neurosphere-forming 
potential following injury, we injected floxed GFP-Reporter mice with the AAV-iCre viral 
vector driven by GFAP expression (see Section 2.5.4) in the intact cortical gray matter to 
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label resident astrocytes. SW lesions were inflicted in the injected area 2 weeks after 
injection, and animals were sacrificed 5 days later for immunohistochemical analysis or 
neurosphere assay (Figure 21A). 
 
Figure 21. Permanent labeling of cortical cells through injection of AAV-iCre in floxed GFP-
Reporter mice. (A) Experimental paradigm used for specific and permanent labeling of cortical 
cells. Mice injected in the same experimental batch were either perfused for 
immunohistochemical analysis or taken for neurosphere assay. (B) Overview of injection site in 
the ipsilateral cortex with widespread GFP expression throughout the cortical gray matter. GFP+ 
cells could also be found in contralateral cortex, as well as GFP+ fibers in the corpus callosum. (C) 
Higher magnifications of areas containing GFP-labeled cells and processes, with corresponding 
locations depicted in (b). (D) In the SEZ there were virtually no GFP-labeled cells, confirming this 
experimental setting to be suitable for the following neurosphere assay analysis. 
Immunohistochemical analysis of injected brains showed a widespread labeling 
of cells throughout all layers of the ipsilateral cortex, detected through GFP expression 
(Figure 21B). Labeling was present in, but not restricted to astrocytes, as it could be 
Results 
84 
clearly seen in layer 5 cortical neurons (Figure 21B). Moreover, there were labeled 
axonal fibers in the corpus callosum and in many cells (including neurons) in the 
contralateral hemisphere, indicating axonal transport of viral particles (Figure 21B,C). 
Furthermore, a few GFP-labeled fibers were identified in the hippocampus (Figure 
21B,C). 
Importantly, virtually no GFP-labeled cells were present in the SEZ (Figure 21D) 
in the animals analyzed. Therefore, with this experimental paradigm we were able to 
successfully label cortical cells in a permanent and region-specific manner. 
Animals that were injected in parallel to the ones analzyed via 
immunohistochemistry were taken for preparation of cell cultures and neurosphere 
assay analysis. By using a fluorescent lamp we could identify the injection site (Figure 
22A) and used this to restrict the cortical dissection to GFP-expressing tissue (Figure 
22B). 
Consistent with our results from immunohistochemical analysis, virtually all of 
the neurospheres originated from SEZ tissue were negative for GFP (Figure 22C). On the 
other hand, in cultures prepared from injured cortical tissue there were GFP+ 
neurospheres, indicating that cells of cortical origin can give rise to neurospheres 
following an invasive injury, such as the SW lesion (Figure 22D). Of note, many of the 
cortical neurospheres were GFP-, which could have two possible explanations. Either 
they are originated from cortical cells that were not infected or did not turn on the 
expression of GFP, or they are formed by cells of non-cortical origin that migrate to the 
lesion site. 
Altogether, these results cannot rule out the possibility that cells of non-cortical 
origins contribute to the pool of neurosphere-forming cells at the lesion site. However, 
this evidence demonstrates that cells within the cortical parenchyma are able to 
dedifferentiate and give rise to neurospheres following injury. 
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Figure 22. Cortical cells give rise to neurospheres following injury, as observed through 
AAV-iCre injection in floxed GFP-reporter mice. (A) Overview of injected brains prior to 
dissection in which strong GFP fluorescence area can be seen at the site of injection and lesion. (B) 
Cortical tissue samples after dissection are labeled with GFP (n=4). (C) Virtually no neurospheres 
originated from the SEZ were GFP+. (D) Cortical cells gave rise to GFP+ and GFP- neurospheres 
following injury. 
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4 Discussion 
Although it has been shown that cerebral cortical reactive astrocytes exhibit stem 
cell potential in vitro, it remains largely unknown if these cells can enact this potential in 
vivo when exposed to different environmental cues. Through this study we achieved a 
better understanding of “if” and “how” reactive astrocytes can be modulated in different 
conditions in vivo. 
4.1 Reactive astrocytes can re-enter the cell cycle upon 
repetitive lesions 
By employing two independent experimental approaches – proliferative 
population analysis through a dual-labeling strategy with BrdU and EdU (Figure 5), and 
clonal analysis with GLAST/Confetti mice (Figure 8) - we have shown that astrocytes can 
undergo more than one round of cell division upon repetitive injuries. Even though the 
proportion of astrocytes that can be activated re-enter the cell cycle in this condition is 
significant (10-14% of proliferating astrocytes, Figures 8H,12D), their progeny is rather 
limited compared to other glial cell populations (Schneider et al., 2016; Tay et al., 2017), 
as we could not observe any clones that were bigger than 3 cells in our clonal analysis 
(Figure 8H). This limitation also reflects the results we obtained in the neurosphere 
assay, as a second lesion did not induce any observable changes in the self-renewal and 
differentiation potential of reactive astrocytes in vitro (Figure 9). 
Although our data show that astrocyte self-renewal as one hallmark of stem cell 
identity is limited in vivo, this property can be modulated by injury conditions and the 
presence of monocytes in the lesion site. Upon the absence of infiltrating monocytes 
there was a 2-fold increase in the proportion of self-renewing GFAP+/BrdU+/EdU+ 
astrocytes in the penumbra of CCR2-/- mice compared to WT animals following repetitive 
lesions (Figure 12D,F). Monocytes evidently play an important role in regulating 
astrocyte recruitment into proliferation, and it would be interesting to investigate which 
mechanisms or factors are involved in this process. In a previous study it was shown 
through proteome analysis in CCR2-/- compared to WT mice that at 5 days after SW injury 
there is an increase in GSK3a, a protein involved in many signaling pathways that are 
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important for proliferation (such as Wnt, EGF, retionoic acid and PDGF), as well as 
regulation of many proteins that interact with EGFR, which is an important receptor for 
activation of aNSC and reactive astrocyte proliferation (Frik et al., 2018). Furthermore, in 
this study it was shown that there is a decreased permeability of the BBB in CCR2-/- mice 
in the acute phase after injury (3 dpi), which could have an effect on the signals that are 
entering the penumbra and modulating astrocyte proliferation (Frik et al., 2018).  
Another intriguing question would be to assess whether the new astrocytes that 
are generated after single or repetitive injuries perform the same functions as the 
astrocytes that were lost through damage. In a study with NG2-glia ablation, for example, 
even though the NG2 cell population was fully restored in a short time after depletion, 
mice suffered from motor dysfunctions due to differentiation deficits in the newly 
generated NG2-glia (Schneider et al., 2016). Therefore, in the context of single and 
repetitive traumatic brain injuries, it would be interesting to evaluate whether the 
different groups of subsets of reactive astrocytes are functionally equivalent or if newly 
generated astrocytes in these injury conditions show functional deficits. 
Moreover, it has been recently shown that there is a big degree of astrocyte 
heterogeneity within the cortex, evidenced by differences in morphology and gene 
expression profiles of astrocytes in distinct cortical layers (Lanjakornsiripan et al., 2018). 
There seems to be layer-specific interactions between astrocytes and neurons, and 
astrocytes could have layer-specific functions. It would be interesting to evaluate 
whether these specific profiles and functions are maintained in such a layer-specific 
organization following damage. 
4.2 Astrocyte proliferative pool is adaptable and driven 
towards homeostatic maintenance of astrocyte population 
Another key finding of this study is that the proliferative capacity of astrocytes is 
not strictly restricted to a fixed subset of cells, but can actually be activated in different 
sets of astrocytes by repetitive lesions. Our data show that upon a second lesion there is 
substantial recruitment of previously quiescent astrocytes into proliferation 
(GFAP+/EdU+ cells, Figure 5C). Therefore, even though a greater pool of parenchymal 
astrocytes located at the lesion site is potentially able to proliferate, only a restricted 
number of them actually enter cell division following a single injury (around 50% of 
astrocytes 250 µm away from the lesion core, Figure 5B). 
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Surprisingly, the number of total parenchymal astrocytes was consistently 
maintained (Figures 5B, 8D, 12B) after single and repetitive lesions across all genotypes 
we analyzed (WT, GLAST/Confetti and CCR2-/- mice). Astrocyte loss after traumatic brain 
injury has been previously described (Frik et al., 2018; Zhao et al., 2003), and it has been 
shown that astrocyte loss is restored through cell proliferation in young adult mice (Frik 
et al., 2018; Heimann et al., 2017). Nevertheless, it is interesting to note that, even after 
double lesions, the astrocytic population numbers were reestablished over the time 
course of a few days. Altogether, this astrocyte population recovery that we observed is a 
strong indicative of the existence of a mechanism for maintenance of the astrocytic 
population at homeostatic cell numbers, as it has been described for other glial cells 
(NG2-glia and microglia) (Elmore et al., 2014; Hughes et al., 2013; Jäkel and Dimou, 
2017). 
Interestingly, we observed that this recovery can be achieved through different 
strategies, in other words, through the activation of different subsets of astrocytes into 
proliferation. In WT animals we observed a preferential recruitment of previously 
quiescent astrocytes into proliferation upon a second injury (Figure 12D,F). However, in 
the absence of invading monocytes we observed a clear shift towards an increase of 
astrocyte cell-cycle reentry, and this was accompanied by a reduced recruitment of 
quiescent astrocytes into proliferation (Figure 12D,F). Although different subsets of 
astrocytes are recruited into proliferation in the absence or presence of invading 
monocytes, in both scenarios the same end result of reestablishment of parenchymal 
astrocyte numbers was achieved (Figure 12B). 
It has been shown that in the aged brain there is an impaired recovery of 
astrocytic loss following traumatic brain injury, and that this failure is mainly due to 
deficits in astrocytic cell division and their lowered response to proliferative stimuli 
(Heimann et al., 2017). We showed evidence that suggests this deficit is intrinsically 
regulated by changes in the expression levels of important key regulators of cell 
proliferation (Figure 13) (Heimann et al., 2017). It would be interesting to investigate the 
mechanisms involved in shutting down the proliferative machinery that we observe in 
young astrocytes that occurs during aging and turns them refractory to proliferative 
signals, leading to a disruption in the homeostatic maintenance of their population 
numbers following injury. 
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Altogether, our findings provide insights into a unique adaptation capacity of the 
proliferative repertoire of astrocytes that leads to the prevention of astroglia depletion in 
distinct lesion microenvironments. 
4.3 Impairment of monocyte infiltration leads to changes in the 
overall cellular environment at the penumbra 
We have shown through immunohistochemical analysis of sections with single 
and double lesioned brains that the non-astrocytic (GFAP-) proliferative population is 
mostly comprised of microglia/macrophages (Figure 10B,D). After a single injury in WT 
animals, we observed an exacerbated increase in the number of proliferating Iba1+ 
microglia/macrophages, which ultimately led to an increase of the total Iba1+ population 
(Figure 10B,C). This phenomenon of exacerbated response of macrophages in the CNS to 
a second pathological insult has been described in different types of injury and is known 
as microglia priming (Witcher et al., 2015). 
It was surprising to see, however, that in the absence of invading monocytes the 
numbers of proliferative non-astrocytic cells was comparable following single and 
repetitive injuries. Since most of the GFAP- proliferating cells in WT animals were Iba1+ 
microglia/macrophages, one can speculate that in CCR2-/- animals these cells suffer an 
exhaustion due to their exacerbated proliferation following a first insult (possibly due to 
an overload caused by the lack of infiltrated monocytes) and are less responsive to a 
second insult. In order to confirm this speculative hypothesis it is necessary to further 
investigate how the monocyte-free environment affects the proliferation of microglia in 
response to repetitive injuries in the CCR2-/- mice. 
4.4 Neurosphere-derived cortical reactive astrocytes are 
largely unable to give rise to neurons in vivo 
Parenchymal cortical astrocytes have been shown to acquire stem cell potential 
following invasive brain injury and can give rise to different cell types in vitro, including 
neurons (Buffo et al., 2008; Shimada et al., 2012; Sirko et al., 2013). It has also been 
shown that striatal astrocytes have a latent neurogenic program and can generate 
immature neurons in vivo upon stroke (Magnusson et al., 2014). Since the cerebral cortex 
is a gliogenic environment and does not support neurogenesis (Seidenfaden et al., 2006), 
we questioned whether cortical reactive astrocytes would be able to give rise to neurons 
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in vivo if relocated to environments with robust neurogenesis – the adult hippocampal 
DG and the developing forebrain of the E13 embryo. 
Although reactive astrocytes derived from cortical neurospheres could survive in 
the host brain following transplantation, they largely failed to give rise to immature and 
mature neurons (DCX+ and NeuN+ cells) at 2 and 4 wpt and remained within the glial cell 
lineage (GFAP+ or Olig2+ cells) both in the adult hippocampal neurogenic niche (Figure 
15), and in the developing embryonic brain (Figure 17). These results are consistent with 
a previous report in which reactive astrocytes derived from the cortical peri-infarct area 
after stroke did not give rise to neuronal cells when transplanted into adult neurogenic 
niches (SEZ , RMS and DG) or the neonatal brain (Shimada et al., 2012). 
Therefore, although cortical reactive astrocytes can be instructed to give rise to 
neurons through forced reprogramming in vitro (Heinrich et al., 2010) and in vivo (Buffo 
et al., 2005; Gascón et al., 2016, 2017), the signals present in the DG neurogenic niche or 
in the E13 developing brain are not successful in locally supporting neuronal 
differentiation in these cells.  
Surprisingly, also neurosphere-derived cells from the SEZ, which contain bona 
fide aNSCs, were not successful in giving rise to mature neurons in the adult DG within 4 
weeks after transplantation, even though they could generate a substantial amount of 
neuroblasts in this neurogenic niche (Figure 15). These results are contrary to another 
study, in which rat SEZ neurospheres were transplanted into the DG, and 2 weeks after 
transplantation 35% of the transplanted cells exhibited immunohistochemical and 
morphological features of hippocampal granule cell neurons (Richardson et al., 2005). 
This inconsistency could be due to species-specific differences in the neurogenic niches 
and therefore it would be interesting to confirm this on further studies. 
Furthermore, although these aNSCs could give rise to a few mature NeuN-
expressing neurons in different brain regions of the developing brain, their neurogenic 
potential was mostly confined to their own OB neurogenic niche, as at 4 wpt only the 
neurons generated in this region could survive (Figure 17). 
Altogether, although both the adult DG and the E13 embryonic brain are pro-
neurogenic environments that can support and orient some levels of neuronal 
differentiation for non-endogenous SEZ aNSCs, it seems that these cells are very much 
restricted and unresponsive to neuronal differentiation cues from neurogenic niches 
other than their own. 
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4.5 Neurosphere-derived cells from the SEZ and injured cortex 
show very distinct differentiation profiles upon 
transplantation in neurogenic environments 
Although cells derived from reactive cortical neurospheres did not give rise to 
neurons in vivo in both neurogenic environments we evaluated, it is important to note 
that these cells showed a clearly distinct differentiation profile compared to cells from 
SEZ-derived neurospheres. 
In the adult DG, cells derived from SEZ neurospheres gave rise to a substantial 
amount of oligodendrocytic cells (Olig2+, 17-30%) and immature neurons (DCX+, 22-
32%) at 2 and 4 wpt, whereas cells derived from injured cortex neurospheres gave rise 
to few oligodendrocytic cells (Olig2+, 3-5%) and to virtually no immature neurons (DCX+, 
0%) over the same time points analyzed (Figure 15). 
Moreover, when transplanted intraventricularly into the E13 brain, SEZ 
neurosphere-derived cells could migrate into the OB and generate mature NeuN-
expressing neurons. Additionally, these cells could also give rise, albeit at a lower 
frequency and only at 2 wpt, to mature neurons in the hypothalamus and midbrain 
(Figure 17). On the other hand, injured cortex neurosphere-derived cells could neither 
migrate into the OB, nor give rise to neurons in any brain region, even in the 
hypothalamus and midbrain, where they were commonly found to integrate (Figures 16 
and 17). 
Taken together, in light of recent debate regarding the origin and identity of 
neurosphere-forming cells in the injured cortex, our results from transplantation 
experiments with SEZ- and injured cortex-derived neurospheres bring clear evidence 
that the neurosphere-forming cells in these two regions are distinct from each other, 
both in their differentiation and migration profiles in vivo. This new evidence highlights 
the importance of performing additional experiments to further investigate and evaluate 
this question, which is the last topic of this thesis. 
4.6 Cortical cells give rise to neurospheres after injury 
10 years ago it was shown that cortical reactive astrocytes de-differentiate after 
injury and acquire stem cell potential, evidenced by the formation of self-renewing, 
multipotent neurospheres in vitro (Buffo et al., 2008). When this phenomenon was first 
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described, evidence was provided to classify the neurosphere-forming cells as resident 
cortical parenchymal astrocytes that de-differentiate and acquire stem cell properties 
upon traumatic brain injury. However, recently new evidence has been shown for an 
alternative hypothesis, namely, that the neurosphere-forming cells present at the cortical 
lesion site are actually SEZ aNSCs that are generated at the lateral ventricle and migrate 
to the cortex upon an ischemic injury (Faiz et al., 2015). 
Both studies have some shortcomings in the experimental paradigms used to 
analyze the origin of the cortical neurospheres and possible contributions from cells of 
other brain regions. In Buffo et al. 2008, this was analyzed through injection of VSVG-
pseudotyped lentiviral vector containing GFP reporter into the SEZ ipsilateral to the site 
of SW injury to label the cells, and could not identify any cell migration from SEZ cells 
into the cortex through immunohistochemistry or FACS analysis. The limitation of this 
paradigm is that the labeling obtained in SEZ cells through lentiviral vector injections 
was very low, more precisely, 2.6% of SEZ cells were GFP+. Therefore, the absence of 
evidence for migration of SEZ cells to the cortex does not necessarily mean that this 
would not be the case if a greater number of cells could be labeled and followed. 
On the other hand in the Faiz. et al 2015 study, although they can follow a 
substantial number of SEZ cells through fate-mapping in the Nestin-CreERT2 mouse 
model, they do not provide convincing controls to show that they have specific labeling of 
SEZ cells, but not of cortical cells.  
Therefore, we thought it was important, to revisit this fundamental question and 
assess if the discrepancy of the data between the studies is due to the different injury 
models used (traumatic lesion or ischemic injury), or if indeed one of the two hypothesis 
would not be sustained in light of new results gathered from further experiments that 
could address possible methodological shortcomings in the studies performed so far. 
Data gathered on in vitro and in vivo properties of neurospheres derived from SEZ 
aNSCs and cortical reactive astrocytes show an obvious difference in the self-renewal and 
differentiation properties of these cells. Consistent across different cortical regions and 
also injury types, cells derived from the injured cortex show a lower number of 
neurosphere-formation in primary and also subsequent passages, and also decreased 
size and multipotency compared to SEZ-derived neurospheres (Shimada et al., 2012; 
Sirko et al., 2009, 2013). Furthermore, when transplanted into the brains of neonatal 
mice, neurospheres derived from the SEZ could give rise to neurons, whereas 
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neurospheres derived from the lesioned cortex could not (Shimada et al., 2012). Our 
transplantation study discussed in the previous section also shows the same results: cells 
derived from SEZ neurospheres could give rise to immature neurons in the adult DG and 
to mature neurons in the developing embryonic brain, whereas cells derived from 
injured cortex neurospheres could not (see Section 3.2). 
Taken together, comparative data from SEZ and injured cortex neurospheres 
indicate that either these two neurospheres are generated from different cell types, or if 
the aNSCs do migrate from the SEZ to the lesioned cortex and are the cells that generate 
the cortical neurospheres, they undergo drastic changes in this migration that ultimately 
lead to alterations in their intrinsic program, resulting in differences that can be still seen 
when cells from these two different sources are placed into a new environment. 
We set out to evaluate whether cortical cells could give rise to neurospheres upon 
injury and designed simple experimental paradigms to answer this question, which 
consisted on labeling cortical cells before injury and evaluating if they could give rise to 
neurospheres thereafter. We achieved permanent labeling of cortical cells through the 
double transgenic Emx1-GFP mice, and AAV-iCre injection into the cortex of floxed GFP-
Reporter mice. While in the Emx1-GFP mice there were a few GFP-labeled cells in the SEZ 
(Figure 18) and a few GFP+ neurospheres from the SEZ (Figure 19), in the GFP-Reporter 
mice injected with AAV-iCre there were literally no GFP-labeled cells in the SEZ (Figure 
21) or GFP+ neurospheres from SEZ tissue (Figure 22). Our data from both experimental 
paradigms (but most convincingly from AAV-iCre injected mice) show that cortical cells 
can give rise to neurospheres in vitro after SW lesion. However, with this experimental 
design we cannot exclude that SEZ aNSCs could contribute to neurosphere formation in 
cortical tissue. In order to answer this question, one possibility would be to label SEZ 
cells using the same viral vector and mouse line and performing the neurosphere assay. 
Nonetheless, the positive evidence for neurosphere formation from local cortical 
cells that we have shown is in contradiction with the results from Faiz et al. (2015), 
which means that either these differences are due to lesion-specific differences (between 
SW lesion and ischemic stroke), or due to false conclusions drawn on the aforementioned 
dubious experimental paradigm. It could still well be that part of the neurospheres 
isolated from injured cortical tissue are formed by cells of non-cortical origin, but now 
we can ascertain that cortical cells can give rise to at least part of these neurospheres 
upon SW lesion. 
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4.7 General conclusions 
Our results show that cortical gray matter reactive astrocytes exhibit an overall 
limited stem cell potential (self-renewal and differentiation) in vivo when stimulated in 
different environments and injury conditions. However, our data indicate that astrocyte 
proliferation in the post-traumatic brain is an adaptable process. Our results show that 
astrocyte cycling activity is not restricted to a subset of astrocytes and the activation of 
proliferation of different groups of astrocytes is dynamically regulated by environmental 
cues. Intriguingly, astrocyte proliferation seems to be a tightly regulated process, with a 
strong drive towards population homeostasis. The functional implications of the different 
astrocyte proliferative behaviors and population homeostasis in CNS function remain to 
be seen, and a better comprehension of these processes could forward the advancement 
of approaches to repair the damaged CNS in the future. 
Altogether, the novel findings of this thesis advance the understanding of the 
biology of reactive astrocytes and open many new exciting questions for future 
investigation in this field. 
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